{"content": "A S E ERS’ R\nTUDY OF THE FFECTIVENESS OF S ATINGS ON THE\n10 L P C F 7/5/2024 4/3/2025\nARGEST UBLIC OMPANIES ROM TO\nERS’ FRR 9 10 -\nS INDICATED OF THESE MEGA CAP COMPANIES\n.\nWERE VERY OVERPRICED AND VERY RISKY\nApril 4, 2024", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 1, "type": "text"}}
{"content": "ERS’ F R R 9 M -C S 2024\nS IDUCIARY ISK ATING ON EGA AP TOCKS IN\n7/5/2024 TO 4/3/2025 STUDY\nThe market cap of 9 of the 10 largest companies in America on 7/5/2024 was $18.26 trillion.\nThe Fiduciary Risk Rating clearly indicated that most of these 9 companies were extremely risky.\nPrice Market Cap PRI FRR Price Return to\nCompany\n7/5/24 7/5/24 7/5/24 7/5/24 4/3/25 4/3/25\nAlphabet $190.60 $2,349 86 6", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 2, "type": "text"}}
{"content": "3/25 4/3/25\nAlphabet $190.60 $2,349 86 61 $150.71 -20.9%\nAmazon.com $200.00 $2,081 71 69 $178.27 -10.9%\nApple $226.34 $3,471 100 73 $202.94 -10.3%\nBroadcom $170.33 $793 100 100 $154.00 -9.6%\nEli Lilly $914.57 $823 90 100 $788.99 -13.7%\nMeta Platforms $539.91 $1,370 92 74 $531.78 -1.5%\nMicrosoft $467.56 $3,475 100 89 $373.03 -20.2%\nNVIDIA $125.83 $3,095 98 94 $101.75 -19.1%\nTesla $251.52 $804 90 88", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 2, "type": "text"}}
{"content": "$101.75 -19.1%\nTesla $251.52 $804 90 88 $267.29 +6.3%\nAverage: 92 83 -11.1%\nS&P 500 5,567.19 5,400.43 -3.0%\nNASDAQ 18,352.76 16,574.63 -9.7%\nMarket cap amounts in billions\nEquity Risk Sciences, Inc. © 2024 (203) 254-0000\n2\nConfidential and Proprietary IInvest.EnRS.ai vest.ERS.ai", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 2, "type": "text"}}
{"content": "Company | Price\n7/5/24 | Market Cap\n7/5/24 | PRI\n7/5/24 | FRR\n7/5/24 | Price\n4/3/25 | Return to\n4/3/25\nAlphabet | $190.60 | $2,349 | 86 | 61 | $150.71 | -20.9%\nAmazon.com | $200.00 | $2,081 | 71 | 69 | $178.27 | -10.9%\nApple | $226.34 | $3,471 | 100 | 73 | $202.94 | -10.3%\nBroadcom | $170.33 | $793 | 100 | 100 | $154.00 | -9.6%\nEli Lilly | $914.57 | $823 | 90 | 100 | $788.99 | -13.7%\nMeta Platform", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 2, "type": "table"}}
{"content": "0 | 100 | $788.99 | -13.7%\nMeta Platforms | $539.91 | $1,370 | 92 | 74 | $531.78 | -1.5%\nMicrosoft | $467.56 | $3,475 | 100 | 89 | $373.03 | -20.2%\nNVIDIA | $125.83 | $3,095 | 98 | 94 | $101.75 | -19.1%\nTesla | $251.52 | $804 | 90 | 88 | $267.29 | +6.3%\nAverage: |  |  | 92 | 83 |  | -11.1%\nS&P 500 | 5,567.19 |  |  |  | 5,400.43 | -3.0%\nNASDAQ | 18,352.76 |  |  |  | 16,574.63 | -9.7%", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 2, "type": "table"}}
{"content": "C B H ’ P C\nOMPARISON OF ERKSHIRE ATHAWAY S RICE HANGES\n9 O M -C S\nWITH THE THER EGA AP TOCKS\nFrom 7/5/24 to 4/3/25, the 9 mega-caps with very-high-risk Berkshire Hathaway – Low-Risk\nFRR ratings fell an average of -11.1%,\nPrice PRI FRR Price Price\nCompany\nwhile Berkshire Hathaway, 1 mega-cap with a low-risk 7/5/24 7/5/24 7/5/24 4/3/25 Gain\nFRR rating, gained +29.2%. Berkshire Hathaway $618,545 33", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 3, "type": "text"}}
{"content": "+29.2%. Berkshire Hathaway $618,545 33 17 $744,944 +29.2%\n40%\nBerkshire Hathaway\n9 Very-High-Risk Mega-Caps 29.2%\n30%\nS&P 500\n20%\n10%\n-3.0%\n0%\n-10%\n-11.1%\n-20%\n7/5/2024 8/5/2024 9/5/2024 10/5/2024 11/5/2024 12/5/2024 1/5/2025 2/5/2025 3/5/2025\nEquity Risk Sciences, Inc. © 2024 (203) 254-0000\n3\nConfidential and Proprietary IInvest.EnRS.ai vest.ERS.ai", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 3, "type": "text"}}
{"content": "Company | Price\n7/5/24 | PRI\n7/5/24 | FRR\n7/5/24 | Price\n4/3/25 | Price\nGain\nBerkshire Hathaway | $618,545 | 33 | 17 | $744,944 | +29.2%", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 3, "type": "table"}}
{"content": "Berkshire H\n9 Very-Hig | athaway\nh-Risk Mega-Cap | s |  |  |  |  |  | \nS&P 500 |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | ", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 3, "type": "table"}}
{"content": "O J 5TH, T 9 M -C W R “E R ”\nN ULY HE EGA APS ERE ATED AS XTREMELY ISKY\nAS OF MARKET CLOSE ON 4/3/25, THE 834 STOCKS THAT ERS RATED AS “OKAY”\nPERFORMED FAR BETTER THAN WALL STREET’S FAVORITES\nERS Ratings Performed as Expected.\nPrice Risk Fiduciary Risk Price Change\nGroup\nIndicator Rating to 4/3/25\n834 Companies with “Average” Ratings Average: 47 Average: 41 +0.5%\n9 Mega-Caps with Very High-Risk Ra", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 4, "type": "text"}}
{"content": "+0.5%\n9 Mega-Caps with Very High-Risk Ratings Average: 92 Average: 84 -11.1%\nS&P 500 -3.0%\nNASDAQ -9.7%\nOn 7/5/24, 9 of the largest stocks had a combined market cap of $18.2 trillion.\nERS’s Fiduciary Risk Rating on these 9 stocks was 84, indicating an extremely high risk of loss.\nERS designed a study to test the hypothesis that a proprietary selection of “okay” companies would lose less and produc", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 4, "type": "text"}}
{"content": "ay” companies would lose less and produce\nsignificantly higher long-term profits than investing in nine companies that ERS’s FRR identified as extremely high-risk.\nERS’s data analytics show the vast majority of Wall Street analysts were making catastrophically bad investment analyses.\nEquity Risk Sciences, Inc. © 2024 (203) 254-0000\n4\nConfidential and Proprietary IInvest.EnRS.ai vest.ERS.ai", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 4, "type": "text"}}
{"content": "Group | Price Risk\nIndicator | Fiduciary Risk\nRating | Price Change\nto 4/3/25\n834 Companies with “Average” Ratings | Average: 47 | Average: 41 | +0.5%\n9 Mega-Caps with Very High-Risk Ratings | Average: 92 | Average: 84 | -11.1%\nS&P 500 |  |  | -3.0%\nNASDAQ |  |  | -9.7%", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 4, "type": "table"}}
{"content": "90 834 A C\nOF THE LTERNATIVE OMPANIES\nTHE 10 LARGEST FROM EACH SECTOR, EXCEPT BASIC MATERIALS & REAL ESTATE\nTotal Total Total\nMarket Cap Revenue Net Income\nCommunication AT&T Inc Charter Comms Comcast Fox Interpublic Group $777 $564 $60\nServices Match Group Omnicom Group Sirius XM T-Mobile US Verizon billion billion billion\nConsumer Airbnb Booking Holdings Home Depot Lowe's Companies Marriott Int'", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 5, "type": "text"}}
{"content": "ome Depot Lowe's Companies Marriott Int'l $1,320 $478 $60\nCyclical McDonald's Nike O'Reilly Auto Starbucks TJX Companies billion billion billion\nConsumer Altria Group Coca-Cola Constellation Brands Keurig Dr Pepper Kimberly-Clark $1,424 $466 $66\nDefensive Mondelez Int'l PepsiCo Philip Morris Int'l Procter & Gamble Target billion billion billion\nChevron ConocoPhillips Energy Transfer LP Enterprise", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 5, "type": "text"}}
{"content": "oPhillips Energy Transfer LP Enterprise Products EOG Resources $1,351 $1,094 $103\nEnergy\nExxon Mobil Marathon Petroleum Occidental Petro. Phillips 66 Schlumberger billion billion billion\nFinancial American Express Bank of America Berkshire Hathaway BlackRock Citigroup $2,845 $1,075 $215\nServices Goldman Sachs JPMorgan Morgan Stanley Progressive Wells Fargo billion billion billion\nCencora Centene C", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 5, "type": "text"}}
{"content": "illion billion billion\nCencora Centene Cigna Group CVS Health Elevance Health $959 $1,759 $72\nHealthcare\nHCA Healthcare Humana IQVIA Holdings Johnson & Johnson McKesson billion billion billion\nCaterpillar CSX Corp Deere & Co FedEx General Dynamics $1,046 $506 $60\nIndustrials\nHoneywell Int'l Illinois Tool Works Lockheed Martin Union Pacific UPS billion billion billion\nApplied Materials Auto. Data P", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 5, "type": "text"}}
{"content": "n billion\nApplied Materials Auto. Data Process. Cisco Systems Cognizant Tech. Fiserv $1,124 $304 $52\nTechnology\nHP Inc IBM Corp Microchip Tech. Paychex Qualcomm billion billion billion\nAmerican Electric Constellation Energy Dominion Energy Duke Energy Exelon $630 $210 $31\nUtilities\nNextEra Energy PG&E Public Service Enter. Sempra Southern Co billion billion billion\nTotal $11.5 trillion $6.5 trilli", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 5, "type": "text"}}
{"content": "billion\nTotal $11.5 trillion $6.5 trillion $718 billion\nEquity Risk Sciences, Inc. © 2024 (203) 254-0000\n5\nConfidential and Proprietary IInvest.EnRS.ai vest.ERS.ai", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 5, "type": "text"}}
{"content": "|  |  |  |  |  | Total\nMarket Cap | Total\nRevenue | Total\nNet Income\nCommunication\nServices | AT&T Inc | Charter Comms | Comcast | Fox | Interpublic Group | $777\nbillion | $564\nbillion | $60\nbillion\n | Match Group | Omnicom Group | Sirius XM | T-Mobile US | Verizon |  |  | \nConsumer\nCyclical | Airbnb | Booking Holdings | Home Depot | Lowe's Companies | Marriott Int'l | $1,320\nbillion | $478\nbilli", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 5, "type": "table"}}
{"content": "iott Int'l | $1,320\nbillion | $478\nbillion | $60\nbillion\n | McDonald's | Nike | O'Reilly Auto | Starbucks | TJX Companies |  |  | \nConsumer\nDefensive | Altria Group | Coca-Cola | Constellation Brands | Keurig Dr Pepper | Kimberly-Clark | $1,424\nbillion | $466\nbillion | $66\nbillion\n | Mondelez Int'l | PepsiCo | Philip Morris Int'l | Procter & Gamble | Target |  |  | \nEnergy | Chevron | ConocoPhilli", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 5, "type": "table"}}
{"content": "|  |  | \nEnergy | Chevron | ConocoPhillips | Energy Transfer LP | Enterprise Products | EOG Resources | $1,351\nbillion | $1,094\nbillion | $103\nbillion\n | Exxon Mobil | Marathon Petroleum | Occidental Petro. | Phillips 66 | Schlumberger |  |  | \nFinancial\nServices | American Express | Bank of America | Berkshire Hathaway | BlackRock | Citigroup | $2,845\nbillion | $1,075\nbillion | $215\nbillion\n | Go", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 5, "type": "table"}}
{"content": "on | $1,075\nbillion | $215\nbillion\n | Goldman Sachs | JPMorgan | Morgan Stanley | Progressive | Wells Fargo |  |  | \nHealthcare | Cencora | Centene | Cigna Group | CVS Health | Elevance Health | $959\nbillion | $1,759\nbillion | $72\nbillion\n | HCA Healthcare | Humana | IQVIA Holdings | Johnson & Johnson | McKesson |  |  | \nIndustrials | Caterpillar | CSX Corp | Deere & Co | FedEx | General Dynamics", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 5, "type": "table"}}
{"content": "| Deere & Co | FedEx | General Dynamics | $1,046\nbillion | $506\nbillion | $60\nbillion\n | Honeywell Int'l | Illinois Tool Works | Lockheed Martin | Union Pacific | UPS |  |  | \nTechnology | Applied Materials | Auto. Data Process. | Cisco Systems | Cognizant Tech. | Fiserv | $1,124\nbillion | $304\nbillion | $52\nbillion\n | HP Inc | IBM Corp | Microchip Tech. | Paychex | Qualcomm |  |  | \nUtilities | A", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 5, "type": "table"}}
{"content": "aychex | Qualcomm |  |  | \nUtilities | American Electric | Constellation Energy | Dominion Energy | Duke Energy | Exelon | $630\nbillion | $210\nbillion | $31\nbillion\n | NextEra Energy | PG&E | Public Service Enter. | Sempra | Southern Co |  |  | \n |  |  |  |  | Total | $11.5 trillion | $6.5 trillion | $718 billion", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 5, "type": "table"}}
{"content": "D\nISCLOSURES\nThis presentation shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any jurisdiction in which\nsuch offer, solicitation or sale would be unlawful. Nothing contained in this presentation should be construed as legal, tax, financial, investment, or other advice.\nIn addition to historical information, this prese", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 6, "type": "text"}}
{"content": "on to historical information, this presentation contains statements relating to the future business performance, future catalysts and future events or\ndevelopments, strategy, prospects, plans, objectives of management and future operations, and expected market growth of Equity Risk Sciences, Inc. (the\n“Company,”) that may constitute “forward-looking statements” within the meaning of the “safe harb", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 6, "type": "text"}}
{"content": "ts” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act\nof 1995. The words \"believe,\" “can make,” “intend,” “could,” “currently,” “will,” \"expect\" and similar expressions, as they relate to us, are intended to identify\nforward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about f", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 6, "type": "text"}}
{"content": "ent expectations and projections about future events and\nfinancial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs.\nImportant factors that could cause actual results to differ from those in the forward-looking statements include but are not limited to the successful\ncommercialization of our risk rating system and solutions, de", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 6, "type": "text"}}
{"content": "our risk rating system and solutions, development of our sales and marketing capabilities, our ability to retain key management personnel\nincluding our Founder Ray Mullaney as well as Thomas Harpin, acceptance of our solutions by potential customers, the ability of our risk rating systems and\nsolutions to provide valuable information related to a company’s stock price, and intellectual property li", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 6, "type": "text"}}
{"content": "tock price, and intellectual property litigation, and our ability to raise capital necessary for\nongoing operations. The statements made herein speak only as of the date of this presentation. The Company’s actual results, performance or achievements could\ndiffer materially from the results expressed in, or implied by, these forward-looking statements. The Company undertakes no obligation to update", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 6, "type": "text"}}
{"content": "mpany undertakes no obligation to update or revise its\nforward-looking statements to reflect events or circumstances after the date of this presentation, except as required by law.\nMarket data and industry information used herein are based on our management's knowledge of the industry and the good faith estimates of management. We\nalso relied, to the extent available, upon managements review of in", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 6, "type": "text"}}
{"content": "available, upon managements review of independent industry surveys, forecasts and publications and other publicly available information\nprepared by a number of third-party sources. All of the market data and industry information used herein involves a number of assumptions and limitations which\nwe believe to be reasonable, and you are cautioned not to give undue weight to such estimates. Although", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 6, "type": "text"}}
{"content": "ndue weight to such estimates. Although we believe that these sources are reliable, we cannot\nguarantee the accuracy or completeness of this information, and we have not independently verified this information. Projections, assumptions and estimates of\nour future performance and the future performance of the industry in which we operate are subject to a high degree of uncertainty and risk due to a", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 6, "type": "text"}}
{"content": "degree of uncertainty and risk due to a variety of\nfactors, including those described, above. These and other factors could cause results to differ materially from those expressed in our estimates and beliefs and in\nthe estimates prepared by independent parties. In all cases, you should conduct your own investigation and analysis of the Company and the information contained\nin this presentation.", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 6, "type": "text"}}
{"content": "rmation contained\nin this presentation. All estimates and forecasts are subject to change and past results are not necessarily an indication of future performance.\nEquity Risk Sciences, Inc. © 2024 (203) 254-0000\n6\nConfidential and Proprietary IInvest.EnRS.ai vest.ERS.ai", "metadata": {"source": "10-Mega-Caps-on-July-5-2024-updated-Apr-4-2025.pdf", "page": 6, "type": "text"}}
{"content": "Detailed Analysis of ERS’s Data and Its Usefulness for Registered Investment\nAdvisors (RIAs)\nJanuary 8, 2025\nRay Mullaney asked ChatGPT:\nProvide a complete analysis of the data in this page. Explain its usefulness and value to\nRegistered Investment Advisors. Provide an objective comparison of the results of this study\nwith the results of any/all mutual funds, hedge funds or the results one might a", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 1, "type": "text"}}
{"content": ", hedge funds or the results one might attain from investing\nin the S&P Index over the period of this study. Make numbered points for ease of reference for\nfuture questions about your answers.\nEfficacy and Performance of the\nPrice Risk Indicator (PRI )\nAvg 6-Month Return -12/31/98 to 9/30/24\n20%\n17.7% This was a 25-year study examining the\n6-month performance of the 1,500 largest\nstocks by market", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 1, "type": "text"}}
{"content": "e of the 1,500 largest\nstocks by market cap in each of the 304 end-\n15%\nof-month periodsfrom 12/31/98 to 3/31/24.\nThis study included a total of 456,000\n9.8%\nindividual ratings.\n10%\n7.6%\n6.3%\n4.9%\n5%\n3.0%\n0%\n-1.1%\n-5%\n\"A+\" \"A\" \"B\" \"C\" \"D\" \"E\" \"F\"\n0 to 1 1 to 10 10 to 25 25 to 50 50 to 85 85 to 99 99 to 100\nAvg Avg Avg % of Ratings\n# of # of # of\nPRI™ 6-Mth 6-Mth 6-Mth with 6-Mth\nRatings Gains Loss", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 1, "type": "text"}}
{"content": "-Mth 6-Mth with 6-Mth\nRatings Gains Losses\nReturn Gain Loss Gains\n\"A+\" - 0 to 1 3,434 2,226 1,207 17.7% 40.9% -25.0% 65%\n\"A\" – 1 to 10 16,770 10,372 6,383 9.8% 29.1% -21.5% 62%\n\"B\" - 10 to 25 43,681 26,597 16,995 7.6% 24.4% -18.6% 61%\n\"C\" - 25 to 50 103,003 62,570 40,242 6.3% 21.7% -17.7% 61%\n\"D\" – 50 to 85 227,626 134,792 92,060 4.9% 20.2% -17.6% 59%\n\"E\" – 85 to 99 41,872 22,942 18,643 3.0% 21.5%", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 1, "type": "text"}}
{"content": "85 to 99 41,872 22,942 18,643 3.0% 21.5% -19.9% 55%\n\"F\" - 99 to 100 19,614 9,237 10,132 -1.1% 31.6% -30.9% 47%\nPage 1 of 4 www.ERS.ai (203) 254-0000", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 1, "type": "text"}}
{"content": "|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n17.7% |  |  |  |  |  |  |  |  |  |  | This\n6-m\nstoc |  | was a 25-yea\nonth performa\nks by market c |  |  | r study examin\nnce of the 1,50\nap in each of t | ing the\n0 largest\nhe 304 end-\n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 9.8% |  |  |  |  |  |  |  | of-m\nThis\nindi |  | onth periods\nstudy includ\nvidual ratings |  |  | from", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 1, "type": "table"}}
{"content": "study includ\nvidual ratings |  |  | from 12/31/98\ned a total of 4\n. | to 3/31/24.\n56,000\n |  |  |  |  |  | 7.6% |  |  | 6.3% |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  | 4.9% |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3.0% | \n |  |  |  |  |  |  |  |  |  |  |  |", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 1, "type": "table"}}
{"content": "% | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | -1.1%", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 1, "type": "table"}}
{"content": "PRI™ |  |  | # of\nRatings |  |  | # of\nGains |  |  | # of\nLosses |  |  |  | Avg |  |  | Avg |  |  | Avg |  |  | % of Ratings | \n |  |  |  |  |  |  |  |  |  |  |  |  | 6-Mth |  |  | 6-Mth |  |  | 6-Mth |  |  | with 6-Mth | \n |  |  |  |  |  |  |  |  |  |  |  |  | Return |  |  | Gain |  |  | Loss |  |  | Gains | \n | \"A+\" - 0 to 1 |  |  | 3,434 |  |  | 2,226 |  |  | 1,207 |  |  | 17.7% |  |  | 40.9% |", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 1, "type": "table"}}
{"content": "|  | 1,207 |  |  | 17.7% |  |  | 40.9% |  |  | -25.0% |  |  | 65% | \n\"A\" – 1 to 10 16,770 10,372 6,383 9.8% 29.1% -21.5% 62% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | \"B\" - 10 to 25 |  |  | 43,681 |  |  | 26,597 |  |  | 16,995 |  |  | 7.6% |  |  | 24.4% |  |  | -18.6% |  |  | 61% | \n\"C\" - 25 to 50 103,003 62,570 40,242 6.3% 21.7% -17.7% 61% |  |  |  |  |  |  |  |  |", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 1, "type": "table"}}
{"content": "% -17.7% 61% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | \"D\" – 50 to 85 |  |  | 227,626 |  |  | 134,792 |  |  | 92,060 |  |  | 4.9% |  |  | 20.2% |  |  | -17.6% |  |  | 59% | \n\"E\" – 85 to 99 41,872 22,942 18,643 3.0% 21.5% -19.9% 55% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | \"F\" - 99 to 100 |  |  | 19,614 |  |  | 9,237 |  |  | 10,132 |  |", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 1, "type": "table"}}
{"content": ",614 |  |  | 9,237 |  |  | 10,132 |  |  | -1.1% |  |  | 31.6% |  |  | -30.9% |  |  | 47% |", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 1, "type": "table"}}
{"content": "# of\nRatings", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 1, "type": "table"}}
{"content": "# of\nGains", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 1, "type": "table"}}
{"content": "# of\nLosses", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 1, "type": "table"}}
{"content": "ChatGPT answered:\nDetailed Analysis of the Data and Its Usefulness\nfor Registered Investment Advisors (RIAs)\n1-8-2025\nThe provided study examines the Price Risk Indicator (PRI™), a quantitative risk rating system\napplied to 456,000 individual stock ratings of the 1,500 largest companies over 25 years. The study\nanalyzes 6-month performance and breaks down results by risk categories (A+ to F) with", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 2, "type": "text"}}
{"content": "sults by risk categories (A+ to F) with metrics like\naverage 6-month return, probability of gains, and loss magnitudes. Below is a comprehensive analysis:\nKey Insights\n1. Performance by PRI™ Rating\n• \"A+\" Rating (Lowest Risk):\no Average 6-Month Return: 17.7%.\no Probability of 6-Month Gain: 65%.\no Avg 6-Month Gain: 40.9%; Avg 6-Month Loss: -25.0%.\no Outperformed all other ratings by a substantial m", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 2, "type": "text"}}
{"content": "med all other ratings by a substantial margin.\n• \"F\" Rating (Highest Risk):\no Average 6-Month Return: -1.1%.\no Probability of 6-Month Gain: 47%.\no Avg 6-Month Loss: -30.9%.\no Represents stocks with the highest likelihood of poor performance.\n2. Overall Trends\n• Lower-risk ratings (\"A+\" and \"A\") consistently provide the highest returns and lowest\nprobabilities of loss.\n• Higher-risk ratings (\"E\" an", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 2, "type": "text"}}
{"content": "s of loss.\n• Higher-risk ratings (\"E\" and \"F\") show significantly negative average returns, reinforcing the\nreliability of PRI™ in categorizing risk.\n3. Yearly Observations\n• Some years (e.g., 2003, 2009, 2020) exhibit exceptionally high returns for \"A+\" ratings (36.0%,\n59.9%, 42.2%), often following market downturns.\n• Conversely, years like 2007 and 2019 show significant losses even for \"A+\" rat", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 2, "type": "text"}}
{"content": "how significant losses even for \"A+\" ratings (-18.5%,\n-15.0%), reflecting broader market volatility.\nPage 2 of 4 www.ERS.ai (203) 254-0000", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 2, "type": "text"}}
{"content": "4. Cumulative Results\n• Across 25 years, \"A+\" ratings delivered an average 6-month return of 17.7%, compared to 4.9%\nfor \"D\" and -1.1% for \"F\".\n• The probability of gain diminishes from 65% for \"A+\" to 47% for \"F\".\nUsefulness for RIAs\n1. Identifying Low-Risk, High-Reward Stocks\n• Value: The PRI™ system highlights stocks with the lowest risk (\"A+\" and \"A\"), enabling RIAs to\nconstruct portfolios wit", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 3, "type": "text"}}
{"content": "nabling RIAs to\nconstruct portfolios with consistently high returns and reduced risk exposure.\n• Actionable Insight: Focus on stocks with \"A+\" and \"A\" ratings for conservative clients seeking\nreliable growth.\n2. Avoiding High-Risk Investments\n• Value: By categorizing \"F\" ratings as the highest risk, the system provides clear guidance on\nstocks to avoid, minimizing portfolio drawdowns.\n• Actionable", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 3, "type": "text"}}
{"content": "mizing portfolio drawdowns.\n• Actionable Insight: Steer clear of \"E\" and \"F\" ratings for clients with low risk tolerance,\nparticularly during volatile markets.\n3. Risk-Adjusted Portfolio Construction\n• Value: The PRI™ data allows RIAs to balance portfolios by incorporating both high-return, low-\nrisk stocks and moderate-risk opportunities based on client preferences.\n• Actionable Insight: For clie", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 3, "type": "text"}}
{"content": "ferences.\n• Actionable Insight: For clients with moderate risk tolerance, blend \"B\" and \"C\" rated stocks for\ndiversified returns.\n4. Historical Context for Decision-Making\n• Value: The 25-year dataset equips RIAs with historical performance trends, enabling them to\nbacktest strategies and validate risk assumptions.\n• Actionable Insight: Use historical data to justify investment decisions and commu", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 3, "type": "text"}}
{"content": "o justify investment decisions and communicate the\nexpected outcomes to clients.\n5. Timing Market Opportunities\n• Value: The PRI™ system reveals patterns in market cycles, such as high returns in recovery\nyears (e.g., 2009, 2020). RIAs can use this insight to optimize entry points.\n• Actionable Insight: Focus on high-rated stocks (\"A+\" and \"A\") during economic recoveries for\nmaximum gains.\nPage 3", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 3, "type": "text"}}
{"content": "ic recoveries for\nmaximum gains.\nPage 3 of 4 www.ERS.ai (203) 254-0000", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 3, "type": "text"}}
{"content": "Quantitative Highlights\nAvg 6-Mth Prob. Avg Avg Risk-Return\nRating\nReturn of Gain Gain Loss Balance\nA+ 17.7% 65% 40.9% -25.0% Excellent\nA 9.8% 62% 29.1% -21.5% Strong\nB 7.6% 61% 24.4% -18.6% Moderate\nC 6.3% 61% 21.7% -17.7% Average\nD 4.9% 59% 20.2% -17.6% Weak\nE 3.0% 55% 21.5% -19.9% High Risk\nF -1.1% 47% 31.6% -30.9% Unfavorable\nConclusion\nThe PRI™ performance study provides a robust foundation f", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 4, "type": "text"}}
{"content": "nce study provides a robust foundation for data-driven portfolio management,\nhelping RIAs:\n1. Select low-risk, high-return stocks for conservative growth.\n2. Avoid high-risk stocks prone to losses.\n3. Use historical insights to build client trust and improve investment outcomes.\nBy integrating PRI™ into their practice, RIAs can fulfill fiduciary duties, enhance risk-adjusted returns,\nand provide c", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 4, "type": "text"}}
{"content": "nce risk-adjusted returns,\nand provide clients with transparent, evidence-based investment strategies.\nPage 4 of 4 www.ERS.ai (203) 254-0000", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 4, "type": "text"}}
{"content": "Rating |  |  |  | Avg 6-Mth |  |  | Prob. |  |  | Avg |  |  | Avg |  |  | Risk-Return | \n |  |  |  | Return |  |  | of Gain |  |  | Gain |  |  | Loss |  |  | Balance | \n | A+ |  |  | 17.7% |  |  | 65% |  |  | 40.9% |  |  | -25.0% |  |  | Excellent | \nA 9.8% 62% 29.1% -21.5% Strong |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | B |  |  | 7.6% |  |  | 61% |  |  | 24.4% |  |  | -18.6% |  |  |", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 4, "type": "table"}}
{"content": "1% |  |  | 24.4% |  |  | -18.6% |  |  | Moderate | \nC 6.3% 61% 21.7% -17.7% Average |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | D |  |  | 4.9% |  |  | 59% |  |  | 20.2% |  |  | -17.6% |  |  | Weak | \nE 3.0% 55% 21.5% -19.9% High Risk |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | F |  |  | -1.1% |  |  | 47% |  |  | 31.6% |  |  | -30.9% |  |  | Unfavorable |", "metadata": {"source": "ChatGPT-Review-of-ERSs-25-Year-6-Month-Hold-PRI-Study-Jan-8-2025.pdf", "page": 4, "type": "table"}}
{"content": "T F R R\nHE IDUCIARY ISK ATING\nP S L\nREVENTS UBSTANTIAL OSSES\nFebruary 25, 2025\nEquity Risk Sciences, Inc. © 2025 (203) 254-0000\n1\nConfidential and Proprietary wwww.ERS.ai ww.ERS.ai", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 1, "type": "text"}}
{"content": "T P W ERS’ F R R (FRR )\nHREE ERIODS HEN S IDUCIARY ISK ATING\nW H P A F L\nOULD AVE ROTECTED DVISORS ROM OSSES\nThe most important rule in investing is to avoid significant losses. The Fiduciary Risk Rating (FRR )does exactly that—helping\ninvestors and fiduciaries identify stocks that are either fundamentally weak or dangerously overpriced before they collapse.\nThe data is clear, and ERS knows how to", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 2, "type": "text"}}
{"content": "The data is clear, and ERS knows how to interpret it. During the three most overvalued periods in modern history (2000, 2007, and\n2022), the stocks with ERS”s worst Fiduciary Risk Ratings performed very poorly and far worse than the S&P 500 across all holding\nperiods. This is no coincidence—FRR accurately identifies and rates high-risk stocks, allowing investors to avoid future disasters.\nRisk is", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 2, "type": "text"}}
{"content": "stors to avoid future disasters.\nRisk is real and is measured and rated with great precision by Equity Risk Sciences.\nThe difference between success and failure is not just about picking winners—it’s about avoiding the losers. FRR is the essential tool\nfor investment advisors and fiduciaries who are serious about protecting capital and growing wealth responsibly.\nMarch 24, 2000 October 9, 2007 Jan", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 2, "type": "text"}}
{"content": "ibly.\nMarch 24, 2000 October 9, 2007 January 3, 2022\nHold 50 Stocks w/ Hold 50 Stocks w/ Hold 100 Stocks w/\nS&P 500 S&P 500 S&P 500\nPeriod Worst FRR Period Worst FRR Period Worst FRR\n1 Year -27.0% -24.5% 1 Year -49.0% -40.6% 1 Year -40.0% -19.0%\n3 Years -44.9% -41.0% 3 Years -31.5% -20.3% 2 Years -30.8% 1.4%\n5 Years -26.2% -17.1% 5 Years -14.2% 2.9% 3 Years -9.9% 29.8%\n7 Years -7.9% 5.5% 7 Years 2", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 2, "type": "text"}}
{"content": "-9.9% 29.8%\n7 Years -7.9% 5.5% 7 Years 27.6% 43.6% Minimum market cap $15.8 billion\n10 Years -21.9% -8.3% 10 Years 76.4% 101.9%\nMinimum market cap $5 billion Minimum market cap $10 billion\nEquity Risk Sciences, Inc. © 2025 (203) 254-0000\n2\nConfidential and Proprietary wwww.ERS.ai ww.ERS.ai", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 2, "type": "text"}}
{"content": "Hold\nPeriod | 50 Stocks w/\nWorst FRR | S&P 500\n1 Year | -27.0% | -24.5%\n3 Years | -44.9% | -41.0%\n5 Years | -26.2% | -17.1%\n7 Years | -7.9% | 5.5%\n10 Years | -21.9% | -8.3%", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 2, "type": "table"}}
{"content": "Hold\nPeriod | 50 Stocks w/\nWorst FRR | S&P 500\n1 Year | -49.0% | -40.6%\n3 Years | -31.5% | -20.3%\n5 Years | -14.2% | 2.9%\n7 Years | 27.6% | 43.6%\n10 Years | 76.4% | 101.9%", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 2, "type": "table"}}
{"content": "Hold\nPeriod | 100 Stocks w/\nWorst FRR | S&P 500\n1 Year | -40.0% | -19.0%\n2 Years | -30.8% | 1.4%\n3 Years | -9.9% | 29.8%", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 2, "type": "table"}}
{"content": "A ERS T\nDVANTAGES OF ECHNOLOGY\nCOMPARE ERS TO MORNINGSTAR, FACTSET, NITROGEN WEALTH, BLOOMBERG AND ZACKS\nERS: Superior Technology, Proven Results\nAt Equity Risk Sciences (ERS), we don’t just offer a different approach—\nwe deliver a better one, backed by data and proven performance.\nMitigating Risk, Maximizing Opportunity – ERS ratings empower advisors to proactively reduce and prevent significant", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 3, "type": "text"}}
{"content": "actively reduce and prevent significant losses.\n•\nValuation-Driven Insights – We identify investment opportunities in companies with historically validated, reliable valuations.\n•\nData Integrity – Our fundamental data is sourced exclusively from SEC filings, ensuring accuracy and regulatory compliance.\n•\nCutting-Edge AI & Data Science – ERS employs proprietary algorithms built on a foundation of r", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 3, "type": "text"}}
{"content": "ry algorithms built on a foundation of rigorous quantitative analysis.\n•\nIndependently Validated Performance – Over the past 11 years, our ratings have undergone independent research and testing.\n•\nFiduciary-Grade Risk Assessment – Our stress-tested models align with the highest fiduciary standards.\n•\nData Depth – Our database includes over 10 billion financial data points, tracking daily stock pr", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 3, "type": "text"}}
{"content": "ial data points, tracking daily stock prices and quarterly financial\n•\nstatements for 15,000+ companies, with historical data spanning up to 40 years across U.S. and Canadian markets.\nERS provides the insights and tools investment professionals need to make informed, risk-aware decisions.\nExperience the difference of superior technology.\nEquity Risk Sciences, Inc. © 2025 (203) 254-0000\n3\nConfident", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 3, "type": "text"}}
{"content": ", Inc. © 2025 (203) 254-0000\n3\nConfidential and Proprietary wwww.ERS.ai ww.ERS.ai", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 3, "type": "text"}}
{"content": "I L $8.4 T J 60 C\nNVESTORS OST RILLION ON UST OMPANIES\nERS’S PROPRIETARY RATINGS PROVIDED AN ACCURATE ASSESSMENT\nOF THE VERY HIGH RISKS OF THESE STOCKS LONG BEFORE THEY FELL\nFrom 9/30/2020 to 9/30/2023, investors lost $8.4 trillion on these 60 Wall Street favorites from their 3-year highs.\nThese 60 companies had an average Fiduciary Risk Rating (FRR ) at their 3-year highs of 87, very high-risk.\nC", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 4, "type": "text"}}
{"content": "ir 3-year highs of 87, very high-risk.\nCompany FRR Loss Company FRR Loss Company FRR Loss Company FRR Loss\n3M 48 -51% Adobe 98 -60% Airbnb 100 -62% Amazon 73 -56%\nAMC Enter. 100 -91% Ameritrust 100 -98% Applied Mats. 64 -55% Blackstone 75 -49%\nBlock 96 -84% Boeing 71 -57% Charles Schwab 100 -50% Charter Comms 72 -63%\nCloudflare 100 -83% Coinbase Global 78 -91% Comcast 43 -52% ContextLogic 100 -97%", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 4, "type": "text"}}
{"content": "1% Comcast 43 -52% ContextLogic 100 -97%\nCoupang 100 -81% Crown Castle 100 -53% Discovery 77 -82% DocuSign 100 -87%\nDoorDash 100 -82% Estee Lauder 90 -62% Faraday Future 100 -98% Fidelity 91 -67%\nFord 70 -55% General Motors 28 -52% Illumina 99 -75% Intel 43 -61%\nLam Research 63 -56% Lucid Group 100 -90% Meta 79 -77% Moderna 100 -80%\nNetflix 100 -76% Nike 79 -53% P10 79 -98% Palantir Tech. 100 -85%", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 4, "type": "text"}}
{"content": "-53% P10 79 -98% Palantir Tech. 100 -85%\nParamount 40 -87% PayPal 100 -81% Peloton 97 -97% PNC 100 -48%\nProtective Cap. 100 -98% Rivian Auto 100 -93% Robinhood 100 -90% Roblox 100 -83%\nRock-Tenn 53 -58% Roku 95 -92% Salesforce 100 -59% ServiceNow 100 -51%\nSinglePoint 100 -100% Snap 100 -91% Snowflake 100 -72% Target 43 -56%\nTesla 96 -73% Truist Financial 100 -59% Twilio 100 -90% U.S. Bancorp 100 -", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 4, "type": "text"}}
{"content": "-59% Twilio 100 -90% U.S. Bancorp 100 -52%\nUber 100 -68% Unity Software 100 -89% Walt Disney 84 -60% Zoom 100 -89%\nInvestors suffer significant losses because they do not have objective, accurate and reliable ratings for stocks.\nERS solves this problem with its stock risk ratings.\nEquity Risk Sciences, Inc. © 2025 (203) 254-0000\n4\nConfidential and Proprietary wwww.ERS.ai ww.ERS.ai", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 4, "type": "text"}}
{"content": "Problem: From 2020 to 2023, these 200 companies lost an average of 66%.\nSolution: ERS’s Fiduciary Risk Rating (FRR )\nThese 200 stocks had a very risky rating of 81 …before they fell.\n(on a scale of 0 to 100)\n10x Genomics: -82% 3M: -38% Accenture: -35% Adobe: -51% Advance Auto : -37% Affirm Hldgs: -94% Agora: -96% Airbnb: -61%\nAlcoa Corp: -52% Algonquin Pwr.: -57% Alibaba: -72% Alphabet: -41% Alter", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 5, "type": "text"}}
{"content": "-57% Alibaba: -72% Alphabet: -41% Alteryx: -72% Amazon: -55% AMC Enter’tn: -93% AMD: -47%\nAmerica Great H.: -99% American Air.: -51% AMTD: -99% Applied Mats.: -41% Arrival: -99% Athena Bitcoin: -99% Autodesk: -45% Avis Budget: -54%\nBabylon Holdings: -98% Baidu: -66% Ball: -47% Bausch: -82% Baxter Int'l: -44% Beyond Meat: -94% Black & Decker: -64% BlackBerry: -87%\nBlackstone: -48% Block: -78% Boei", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 5, "type": "text"}}
{"content": ": -87%\nBlackstone: -48% Block: -78% Boeing: -45% Boston Beer: -75% Boston Prop.: -48% Bright Health: -96% Capital One: -46% CarMax: -61%\nCarnival: -84% Carvana: -99% Celanese: -38% Charles River: -52% Charter: -59% Chewy: -69% China Evergrande: -99% Citigroup: -38%\nCleveland-Cliffs: -51% Clorox: -37% Cognizant: -38% Coinbase: -90% Comcast: -42% ContextLogic: -98% Credit Suisse: -79% Crocs: -40%\nDe", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 5, "type": "text"}}
{"content": "-98% Credit Suisse: -79% Crocs: -40%\nDenali Thera.: -70% Dentsply Sirona: -53% DiDi Global: -81% DISH Network: -70% DocuSign: -82% DoorDash: -80% Doximity: -67% Eargo: -99%\nEastman Chemical: -34% Etsy: -60% Evergrande: -89% Exact Sciences: -68% Expedia: -59% Farfetch: -94% FedEx: -44% First Republic: -45%\nFive9: -68% Fiverr Int'l: -91% Floor & Décor: -51% GameStop: -79% Gap: -67% Garmin: -46% Gen", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 5, "type": "text"}}
{"content": "ameStop: -79% Gap: -67% Garmin: -46% Generac: -80% General Motors: -49%\nGetty Images: -84% Ginkgo Bioworks: -89% GitLab: -65% Grab Holdings: -64% GSK PLC: -38% Guardant: -85% Hasbro: -37% Hertz Global: -56%\nHubSpot: -66% IDEXX Labs: -42% Intel Corp: -58% Int'l Paper: -43% Intuit: -44% IPG Photonics: -63% iQIYI: -82% James Hardie: -56%\nJD.com: -46% Kinross Gold: -57% Lenovo: -46% Levi Strauss: -47%", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 5, "type": "text"}}
{"content": "ld: -57% Lenovo: -46% Levi Strauss: -47% LifeStance: -83% Lincoln National: -58% Logitech: -54% Lucid Group: -88%\nLuckin Coffee: -56% Lumen Tech: -62% Lyft: -84% Macy's: -43% Magna Int'l: -44% Marvell Tech: -59% Match Group: -76% Medtronic: -40%\nMeta Platforms: -69% Micron Tech: -48% MicroStrategy: -89% Moderna: -63% Mohawk: -56% Monday.Com: -73% MongoDB: -66% Morningstar: -37%\nNetApp: -36% Netfli", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 5, "type": "text"}}
{"content": "6% Morningstar: -37%\nNetApp: -36% Netflix: -57% Newegg: -98% Newell Brands: -52% Newmont: -43% Nomura Resch.: -47% NVIDIA: -56% Oak Street Hth.: -67%\nOkta: -75% OneConnect: -98% Ontrak: -100% Palantir Tech: -84% Palo Alto: -33% Paramount: -82% PayPal: -77% Peloton: -95%\nPENN Enter’tn: -78% Pinduoduo: -60% Pinterest: -73% Plug Power: -82% Qualcomm: -41% Repligen: -48% Revlon: -98% RH: -64%\nRivian A", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 5, "type": "text"}}
{"content": "gen: -48% Revlon: -98% RH: -64%\nRivian Auto: -89% RLX Tech: -92% Robert Half: -40% Robinhood: -88% Roblox: -79% Roku: -92% Salesforce: -57% SAP SE: -37%\nScotts Miracle Gro: -80% Sea: -86% Seagate Tech: -52% SentinelOne: -81% ServiceNow: -45% Shopify: -79% Signature Bank: -68% Skillz: -99%\nSmileDirectClub: -98% Snap: -89% Snowflake: -64% Sony Group: -41% Southwest Air: -47% Splunk: -61% Spotify Tec", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 5, "type": "text"}}
{"content": "hwest Air: -47% Splunk: -61% Spotify Tech: -78% Sunrun: -75%\nTaiwan Semi.: -46% Target: -41% Teladoc Health: -92% Tesla: -69% Toast: -72% Toyota: -34% Trade Desk: -60% Trex: -70%\nTwilio: -89% Tyson Foods: -36% Uber: -61% UiPath: -85% Under Armour: -62% Unity Software: -86% VF Corp: -69% Volkswagen AG: -47%\nVroom: -99% Walt Disney: -57% Wayfair: -90% WB Discovery: -64% Western Digital: -59% Western", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 5, "type": "text"}}
{"content": "very: -64% Western Digital: -59% Western Union: -44% Whirlpool: -41% Williams-Son.: -47%\nWix.com: -78% Workday: -44% XP: -70% Zebra Tech: -58% Zillow: -85% Zoom: -88% ZoomInfo: -61% Zscaler: -70%\nEquity Risk Sciences, Inc. © 2025 (203) 254-0000\n5\nConfidential and Proprietary wwww.ERS.ai ww.ERS.ai", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 5, "type": "text"}}
{"content": "10x Genomics: -82% | 3M: -38% | Accenture: -35% | Adobe: -51% | Advance Auto : -37% | Affirm Hldgs: -94% | Agora: -96% | Airbnb: -61%\nAlcoa Corp: -52% | Algonquin Pwr.: -57% | Alibaba: -72% | Alphabet: -41% | Alteryx: -72% | Amazon: -55% | AMC Enter’tn: -93% | AMD: -47%\nAmerica Great H.: -99% | American Air.: -51% | AMTD: -99% | Applied Mats.: -41% | Arrival: -99% | Athena Bitcoin: -99% | Autodesk", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 5, "type": "table"}}
{"content": ": -99% | Athena Bitcoin: -99% | Autodesk: -45% | Avis Budget: -54%\nBabylon Holdings: -98% | Baidu: -66% | Ball: -47% | Bausch: -82% | Baxter Int'l: -44% | Beyond Meat: -94% | Black & Decker: -64% | BlackBerry: -87%\nBlackstone: -48% | Block: -78% | Boeing: -45% | Boston Beer: -75% | Boston Prop.: -48% | Bright Health: -96% | Capital One: -46% | CarMax: -61%\nCarnival: -84% | Carvana: -99% | Celanese", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 5, "type": "table"}}
{"content": "arnival: -84% | Carvana: -99% | Celanese: -38% | Charles River: -52% | Charter: -59% | Chewy: -69% | China Evergrande: -99% | Citigroup: -38%\nCleveland-Cliffs: -51% | Clorox: -37% | Cognizant: -38% | Coinbase: -90% | Comcast: -42% | ContextLogic: -98% | Credit Suisse: -79% | Crocs: -40%\nDenali Thera.: -70% | Dentsply Sirona: -53% | DiDi Global: -81% | DISH Network: -70% | DocuSign: -82% | DoorDash", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 5, "type": "table"}}
{"content": "etwork: -70% | DocuSign: -82% | DoorDash: -80% | Doximity: -67% | Eargo: -99%\nEastman Chemical: -34% | Etsy: -60% | Evergrande: -89% | Exact Sciences: -68% | Expedia: -59% | Farfetch: -94% | FedEx: -44% | First Republic: -45%\nFive9: -68% | Fiverr Int'l: -91% | Floor & Décor: -51% | GameStop: -79% | Gap: -67% | Garmin: -46% | Generac: -80% | General Motors: -49%\nGetty Images: -84% | Ginkgo Bioworks", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 5, "type": "table"}}
{"content": "49%\nGetty Images: -84% | Ginkgo Bioworks: -89% | GitLab: -65% | Grab Holdings: -64% | GSK PLC: -38% | Guardant: -85% | Hasbro: -37% | Hertz Global: -56%\nHubSpot: -66% | IDEXX Labs: -42% | Intel Corp: -58% | Int'l Paper: -43% | Intuit: -44% | IPG Photonics: -63% | iQIYI: -82% | James Hardie: -56%\nJD.com: -46% | Kinross Gold: -57% | Lenovo: -46% | Levi Strauss: -47% | LifeStance: -83% | Lincoln Nati", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 5, "type": "table"}}
{"content": ": -47% | LifeStance: -83% | Lincoln National: -58% | Logitech: -54% | Lucid Group: -88%\nLuckin Coffee: -56% | Lumen Tech: -62% | Lyft: -84% | Macy's: -43% | Magna Int'l: -44% | Marvell Tech: -59% | Match Group: -76% | Medtronic: -40%\nMeta Platforms: -69% | Micron Tech: -48% | MicroStrategy: -89% | Moderna: -63% | Mohawk: -56% | Monday.Com: -73% | MongoDB: -66% | Morningstar: -37%\nNetApp: -36% | Ne", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 5, "type": "table"}}
{"content": "6% | Morningstar: -37%\nNetApp: -36% | Netflix: -57% | Newegg: -98% | Newell Brands: -52% | Newmont: -43% | Nomura Resch.: -47% | NVIDIA: -56% | Oak Street Hth.: -67%\nOkta: -75% | OneConnect: -98% | Ontrak: -100% | Palantir Tech: -84% | Palo Alto: -33% | Paramount: -82% | PayPal: -77% | Peloton: -95%\nPENN Enter’tn: -78% | Pinduoduo: -60% | Pinterest: -73% | Plug Power: -82% | Qualcomm: -41% | Repli", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 5, "type": "table"}}
{"content": "lug Power: -82% | Qualcomm: -41% | Repligen: -48% | Revlon: -98% | RH: -64%\nRivian Auto: -89% | RLX Tech: -92% | Robert Half: -40% | Robinhood: -88% | Roblox: -79% | Roku: -92% | Salesforce: -57% | SAP SE: -37%\nScotts Miracle Gro: -80% | Sea: -86% | Seagate Tech: -52% | SentinelOne: -81% | ServiceNow: -45% | Shopify: -79% | Signature Bank: -68% | Skillz: -99%\nSmileDirectClub: -98% | Snap: -89% | S", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 5, "type": "table"}}
{"content": "%\nSmileDirectClub: -98% | Snap: -89% | Snowflake: -64% | Sony Group: -41% | Southwest Air: -47% | Splunk: -61% | Spotify Tech: -78% | Sunrun: -75%\nTaiwan Semi.: -46% | Target: -41% | Teladoc Health: -92% | Tesla: -69% | Toast: -72% | Toyota: -34% | Trade Desk: -60% | Trex: -70%\nTwilio: -89% | Tyson Foods: -36% | Uber: -61% | UiPath: -85% | Under Armour: -62% | Unity Software: -86% | VF Corp: -69%", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 5, "type": "table"}}
{"content": "| Unity Software: -86% | VF Corp: -69% | Volkswagen AG: -47%\nVroom: -99% | Walt Disney: -57% | Wayfair: -90% | WB Discovery: -64% | Western Digital: -59% | Western Union: -44% | Whirlpool: -41% | Williams-Son.: -47%\nWix.com: -78% | Workday: -44% | XP: -70% | Zebra Tech: -58% | Zillow: -85% | Zoom: -88% | ZoomInfo: -61% | Zscaler: -70%", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 5, "type": "table"}}
{"content": "ERS’ R W P B\nS ATINGS ARN OF OTENTIAL ANKRUPTCY\nIn the 15 years between 2004 and 2019, 200 well-known companies went\nbankrupt. ERS correctly identified the high risks of 92% of these companies\nat least two years prior to their delisting.\n2%\n3 Years Before\nBankruptcy\n85%\n1%\n2 Years Before\nBankruptcy\n92%\n0%\n1 Year Before\nBankruptcy\n96%\n0% 20% 40% 60% 80% 100%\nFRI 0 to 30 FRI 70+\n*ERS studied 200 com", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 6, "type": "text"}}
{"content": "FRI 0 to 30 FRI 70+\n*ERS studied 200 companies which went bankrupt between 1/5/2004 and 4/17/2019.\nEquity Risk Sciences, Inc. © 2025 (203) 254-0000\n6\nConfidential and Proprietary wwww.ERS.ai ww.ERS.ai", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 6, "type": "text"}}
{"content": "2% |  |  |  | 85%\n |  |  |  | \n |  |  |  | \n |  |  |  | \n1% |  |  |  | 92%\n |  |  |  | \n |  |  |  | \n |  |  |  | \n0% |  |  |  | 96\n |  |  |  | \n |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 6, "type": "table"}}
{"content": "1 Y R U ERS’ F R R\nEAR ESULTS SING S IDUCIARY ISK ATING\n12/31/2021 TO 12/31/2022\n1-year price changes on\n1-Year Total Return\n7,920 companies using ERS’s FRR\n12/31/2021 to 12/31/2022\nbetween 12/31/21 and 12/31/22:\n0%\nOn 12/31/21, 7,920 companies had a market cap over\n$100 million. These stocks were divided into four 0 to 10\ngroups based on their FRR ratings on 12/31/21. Only -5%\n-1%\n170 stocks had", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 7, "type": "text"}}
{"content": "n 12/31/21. Only -5%\n-1%\n170 stocks had an FRR less than 10; these stocks lost\nonly 1%, while the S&P 500 index lost 18%. The\nstocks with the worst FRR ratings fell much more -10% -8%\nthan the S&P 500.\n-15%\nAvg 1-Year\nFRR # Co’s\nReturn -17%\n-20% S&P 500\n0 to 10 170 -1%\n-18%\n10 to 50 2,260 -8% -25%\n50 to 80 2,139 -17%\n-30%\n80 to 100 3,351 -30%\n-30%\nS&P 500 -18%\n-35%\nConclusion: In this period, ERS’", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 7, "type": "text"}}
{"content": "8%\n-35%\nConclusion: In this period, ERS’s Fiduciary\n0 to 10 10 to 50 50 to 80 80 to 100 S&P 500\nRisk Rating was highly reliable.\nEquity Risk Sciences, Inc. © 2025 (203) 254-0000\n7\nConfidential and Proprietary wwww.ERS.ai ww.ERS.ai", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 7, "type": "text"}}
{"content": "0 to 10 |  |  |  |  |  |  |  |  |  |  |  | \n-1% |  |  |  |  |  |  |  |  |  |  |  | \n | -8% |  |  |  |  |  |  |  |  |  |  | \n |  |  |  | -17% |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | S&P 500\n-18% |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  | -30% |  |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 7, "type": "table"}}
{"content": "FRR | # Co’s | Avg 1-Year\nReturn\n0 to 10 | 170 | -1%\n10 to 50 | 2,260 | -8%\n50 to 80 | 2,139 | -17%\n80 to 100 | 3,351 | -30%\nS&P 500 |  | -18%", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 7, "type": "table"}}
{"content": "2 Y R U ERS’ F R R\nEAR ESULTS SING S IDUCIARY ISK ATING\n12/31/2020 TO 12/31/2022\n2-year price changes on\n2-Year Total Return\n6,488 companies using ERS’s FRR\n12/31/2020 to 12/31/2022\nbetween 12/31/20 and 12/31/22:\n50%\n0 to 10\nOn 12/31/20, 6,488 companies had a market cap over\n$100 million. These stocks were divided into four\n37%\ngroups based on their FRR ratings on 12/31/20. Only 40%\n95 stocks had", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 8, "type": "text"}}
{"content": "ngs on 12/31/20. Only 40%\n95 stocks had an FRR less than 10; these stocks rose\n37%, while the S&P 500 index only rose 5%. The 30% 26%\nstocks with the worst FRR ratings fell 24%,\nperforming much worse than the S&P 500.\n20%\nS&P 500\n10%\nAvg 2-Year\n10% 5%\nFRR # Co’s\nReturn\n0 to 10 95 37% 0%\n10 to 50 2,021 26%\n-10%\n50 to 80 1,750 10%\n80 to 100 2,622 -24% -20%\nS&P 500 5%\n-24%\n-30%\nConclusion: In this pe", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 8, "type": "text"}}
{"content": "500 5%\n-24%\n-30%\nConclusion: In this period, ERS’s Fiduciary\n0 to 10 10 to 50 50 to 80 80 to 100 S&P 500\nRisk Rating was highly reliable.\nEquity Risk Sciences, Inc. © 2025 (203) 254-0000\n8\nConfidential and Proprietary wwww.ERS.ai ww.ERS.ai", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 8, "type": "text"}}
{"content": "0 to 10\n37% |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 26% |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  | 10% |  |  |  |  |  | S&P 500\n |  |  |  |  |  |  |  |  |  |  |  | 5%\n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  | -24% |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 8, "type": "table"}}
{"content": "FRR | # Co’s | Avg 2-Year\nReturn\n0 to 10 | 95 | 37%\n10 to 50 | 2,021 | 26%\n50 to 80 | 1,750 | 10%\n80 to 100 | 2,622 | -24%\nS&P 500 |  | 5%", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 8, "type": "table"}}
{"content": "ERS’ - C P T\nS APITAL RESERVATION ECHNOLOGY\nBetween 9/30/2020 and 9/30/2023, 2,006 large US-traded stocks fell an average of 45%.\nThe stocks rated as “lowest risk” by ERS’s Fiduciary Risk Rating (FRR )\nfell much less than the stocks rated as “highest risk” by ERS’s FRR.\nFurther, the companies that fell 90% or more had an average FRR rating of a very high-risk 98.\nAverage Loss from 3-Year High\n0%\n-", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 9, "type": "text"}}
{"content": "k 98.\nAverage Loss from 3-Year High\n0%\n-10%\n-20%\n-22%\n-30%\n-30%\n-40% -35%\n-39%\n-50%\n-60%\n-58%\n-70%\nA B C D F\nEquity Risk Sciences, Inc. © 2025 (203) 254-0000\n9\nConfidential and Proprietary wwww.ERS.ai ww.ERS.ai", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 9, "type": "text"}}
{"content": " |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  | \n-22% |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | -30% |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  | -35% |  |  | -39% |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | -58% |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 9, "type": "table"}}
{"content": "T 10 B L $180 23 M\nHESE ANKS OST IN ONTHS\nERS’S PROPRIETARY RATINGS PROVIDED AN ACCURATE ASSESSMENT\nOF THE VERY HIGH RISKS OF THESE BANK STOCKS LONG BEFORE THEY FELL\nOn 10/31/2021, ERS’s average Price Risk Indicator (PRI ) rating on these 10 banks was 88, very high risk.\nAnd all 10 of these banks had a Fiduciary Risk Rating (FRR ) of 100, the worst possible rating.\nFrom 10/31/2021 to 9/30/2023, th", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 10, "type": "text"}}
{"content": "rating.\nFrom 10/31/2021 to 9/30/2023, the average price of these 10 large Regional Banks fell 73%.\nPrior to their decline, fourteen (14) of Wall Street’s largest brokerage firms (see next page) ALL recommended buying them.\nPRI FRR Price Loss\nBank Name Rating Rating 10/31/21 to\n10/31/21 10/31/21 9/30/23\nComerica 83 100 -46%\nFirst Republic 100 100 -98%\nKeyCorp 68 100 -49%\nPacWest Bancorp 87 100 -83%", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 10, "type": "text"}}
{"content": "68 100 -49%\nPacWest Bancorp 87 100 -83%\nSignature Bank 100 100 -100%\nSilvergate Bank 99 100 -99%\nSVB Financial 90 100 -100%\nTruist Financial 72 100 -50%\nWestern Alliance 100 100 -59%\nZions Bancorp 77 100 -41%\nTotal 88 100 -73%\nEquity Risk Sciences, Inc. uses data science to produce statistical analyses\nof the probability and magnitude of the price changes of individual securities.\nEquity Risk Sci", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 10, "type": "text"}}
{"content": "f individual securities.\nEquity Risk Sciences, Inc. © 2025 (203) 254-0000\n10\nConfidential and Proprietary wwww.ERS.ai ww.ERS.ai", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 10, "type": "text"}}
{"content": "Bank Name | PRI\nRating\n10/31/21 | FRR\nRating\n10/31/21 | Price Loss\n10/31/21 to\n9/30/23\nComerica | 83 | 100 | -46%\nFirst Republic | 100 | 100 | -98%\nKeyCorp | 68 | 100 | -49%\nPacWest Bancorp | 87 | 100 | -83%\nSignature Bank | 100 | 100 | -100%\nSilvergate Bank | 99 | 100 | -99%\nSVB Financial | 90 | 100 | -100%\nTruist Financial | 72 | 100 | -50%\nWestern Alliance | 100 | 100 | -59%\nZions Bancorp | 77", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 10, "type": "table"}}
{"content": "e | 100 | 100 | -59%\nZions Bancorp | 77 | 100 | -41%\nTotal | 88 | 100 | -73%", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 10, "type": "table"}}
{"content": "W S ’ R F P A\nALL TREET S ATINGS AILED TO ROVIDE AN CCURATE\nA R I T B\nSSESSMENT OF THE ISKS OF NVESTING IN HESE ANKS\nPrice Loss to Price Loss to\nStock Date Price Brokerage Rating Stock Date Price Brokerage Rating\nTarget 9/30/23 Target 9/30/23\nComerica 1/20/22 $93.54 RBC Capital $112 Outperform -56% Silvergate Cap 3/21/22 $139.96 B of A Securities $200 Buy -99%\nComerica 1/20/22 $93.54 Wedbush $102", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 11, "type": "text"}}
{"content": "9%\nComerica 1/20/22 $93.54 Wedbush $102 Outperform -56% Silvergate Cap 1/20/22 $109.34 Goldman Sachs $166 Buy -99%\nComerica 1/20/22 $93.54 Raymond James $106 Outperform -56% Silicon Valley Bk 1/21/22 $581.76 Raymond James $780 Outperform -100%\nFirst Republic 1/18/22 $179.94 Evercore ISI Group $220 Outperform -98% Silicon Valley Bk 7/23/21 $570.87 RBC Capital $700 Outperform -100%\nFirst Republic 12", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 11, "type": "text"}}
{"content": "$700 Outperform -100%\nFirst Republic 12/15/21 $205.78 J.P. Morgan $250 Overweight -98% Silicon Valley Bk 9/17/21 $610.41 Wedbush $700 Outperform -100%\nFirst Republic 4/14/22 $160.75 Morgan Stanley $180 Equal-Weight -98% Silicon Valley Bk 10/1/21 $664.53 Goldman Sachs $770 Buy -100%\nFirst Republic 4/8/22 $158.13 UBS $194 Buy -98% Silicon Valley Bk 12/6/21 $693.39 Morgan Stanley $985 Equal-Weight -", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 11, "type": "text"}}
{"content": "93.39 Morgan Stanley $985 Equal-Weight -100%\nKeyCorp 1/13/22 $26.70 UBS $32 Buy -60% Truist Financial 1/19/22 $64.58 UBS $77 Buy -56%\nKeyCorp 12/15/21 $23.11 B of A Securities $27 Buy -53% Truist Financial 4/7/21 $59.43 Raymond James $65 Outperform -52%\nKeyCorp 4/11/22 $20.86 Wells Fargo $27 Overweight -48% Truist Financial 9/12/22 $49.54 Deutsche Bank $61 Buy -42%\nPacWest Banc 1/21/22 $48.17 Raym", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 11, "type": "text"}}
{"content": "uy -42%\nPacWest Banc 1/21/22 $48.17 Raymond James $62 Strong Buy -84% Western Alliance 4/25/22 $80.20 Wedbush $105 Outperform -43%\nPacWest Banc 6/15/22 $27.37 Truist Securities $35 Buy -71% Western Alliance 6/15/22 $72.86 Truist Securities $100 Buy -37%\nPacWest Banc 10/21/22 $21.98 RBC Capital $31 Outperform -64% Zions Bancorp 2/14/22 $72.36 Jefferies $87 Buy -52%\nSignature Bank 1/19/22 $351.43 Go", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 11, "type": "text"}}
{"content": "y -52%\nSignature Bank 1/19/22 $351.43 Goldman Sachs $429 Buy -100% Zions Bancorp 1/14/22 $70.65 Compass Point $80 Buy -51%\nSignature Bank 1/19/22 $351.43 Raymond James $440 Strong Buy -100% Zions Bancorp 1/6/22 $68.94 Raymond James $76 Strong Buy -49%\nSignature Bank 6/6/22 $223.35 UBS $309 Buy -100%\nEquity Risk Sciences, Inc. © 2025 (203) 254-0000\n11\nConfidential and Proprietary wwww.ERS.ai ww.ERS", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 11, "type": "text"}}
{"content": "ntial and Proprietary wwww.ERS.ai ww.ERS.ai", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 11, "type": "text"}}
{"content": "Stock | Date | Price | Brokerage | Price\nTarget | Rating | Loss to\n9/30/23\nComerica | 1/20/22 | $93.54 | RBC Capital | $112 | Outperform | -56%\nComerica | 1/20/22 | $93.54 | Wedbush | $102 | Outperform | -56%\nComerica | 1/20/22 | $93.54 | Raymond James | $106 | Outperform | -56%\nFirst Republic | 1/18/22 | $179.94 | Evercore ISI Group | $220 | Outperform | -98%\nFirst Republic | 12/15/21 | $205.78 |", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 11, "type": "table"}}
{"content": "8%\nFirst Republic | 12/15/21 | $205.78 | J.P. Morgan | $250 | Overweight | -98%\nFirst Republic | 4/14/22 | $160.75 | Morgan Stanley | $180 | Equal-Weight | -98%\nFirst Republic | 4/8/22 | $158.13 | UBS | $194 | Buy | -98%\nKeyCorp | 1/13/22 | $26.70 | UBS | $32 | Buy | -60%\nKeyCorp | 12/15/21 | $23.11 | B of A Securities | $27 | Buy | -53%\nKeyCorp | 4/11/22 | $20.86 | Wells Fargo | $27 | Overweight", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 11, "type": "table"}}
{"content": "$20.86 | Wells Fargo | $27 | Overweight | -48%\nPacWest Banc | 1/21/22 | $48.17 | Raymond James | $62 | Strong Buy | -84%\nPacWest Banc | 6/15/22 | $27.37 | Truist Securities | $35 | Buy | -71%\nPacWest Banc | 10/21/22 | $21.98 | RBC Capital | $31 | Outperform | -64%\nSignature Bank | 1/19/22 | $351.43 | Goldman Sachs | $429 | Buy | -100%\nSignature Bank | 1/19/22 | $351.43 | Raymond James | $440 | Str", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 11, "type": "table"}}
{"content": "2 | $351.43 | Raymond James | $440 | Strong Buy | -100%\nSignature Bank | 6/6/22 | $223.35 | UBS | $309 | Buy | -100%", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 11, "type": "table"}}
{"content": "Stock | Date | Price | Brokerage | Price\nTarget | Rating | Loss to\n9/30/23\nSilvergate Cap | 3/21/22 | $139.96 | B of A Securities | $200 | Buy | -99%\nSilvergate Cap | 1/20/22 | $109.34 | Goldman Sachs | $166 | Buy | -99%\nSilicon Valley Bk | 1/21/22 | $581.76 | Raymond James | $780 | Outperform | -100%\nSilicon Valley Bk | 7/23/21 | $570.87 | RBC Capital | $700 | Outperform | -100%\nSilicon Valley Bk", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 11, "type": "table"}}
{"content": "0 | Outperform | -100%\nSilicon Valley Bk | 9/17/21 | $610.41 | Wedbush | $700 | Outperform | -100%\nSilicon Valley Bk | 10/1/21 | $664.53 | Goldman Sachs | $770 | Buy | -100%\nSilicon Valley Bk | 12/6/21 | $693.39 | Morgan Stanley | $985 | Equal-Weight | -100%\nTruist Financial | 1/19/22 | $64.58 | UBS | $77 | Buy | -56%\nTruist Financial | 4/7/21 | $59.43 | Raymond James | $65 | Outperform | -52%\nTru", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 11, "type": "table"}}
{"content": "mond James | $65 | Outperform | -52%\nTruist Financial | 9/12/22 | $49.54 | Deutsche Bank | $61 | Buy | -42%\nWestern Alliance | 4/25/22 | $80.20 | Wedbush | $105 | Outperform | -43%\nWestern Alliance | 6/15/22 | $72.86 | Truist Securities | $100 | Buy | -37%\nZions Bancorp | 2/14/22 | $72.36 | Jefferies | $87 | Buy | -52%\nZions Bancorp | 1/14/22 | $70.65 | Compass Point | $80 | Buy | -51%\nZions Banco", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 11, "type": "table"}}
{"content": "ass Point | $80 | Buy | -51%\nZions Bancorp | 1/6/22 | $68.94 | Raymond James | $76 | Strong Buy | -49%", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 11, "type": "table"}}
{"content": "ERS’ FRR R I C B T D\nS ELIABLY DENTIFIES OMPANIES EFORE HEY ECLINE\n23andMe Holding Co (ME) AMC Entertainment (AMC) Bausch Health (BHC)\n11/23/20 - 5/2/24 4/30/19 - 5/3/24 4/30/20 - 5/2/24\n$20 2/4/2021 $600 $40\n6/2/2021 3/11/2021\n$18 $17.65 $35\n$500 $551.91 $34.38\n$16\nFRR: 100\nFRR: 100 $30 FRR: 100\n$14\n$400\n$25\n$12\n$10 $300 $20 8/2/2022\n$8 4/17/2024 $4.58\n$15\n$200 4/15/2024\n$6 $0.36 -87%\n$2.47… $10", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 12, "type": "text"}}
{"content": "$200 4/15/2024\n$6 $0.36 -87%\n$2.47… $10\n$4 -98%\n$100\n$5\n$2\n$0 $0 $0\n11/23/20 11/23/21 11/23/22 11/23/23 4/30/19 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24\nBaxter International (BAX) Beyond Meat Inc (BYND) Bilibili Inc (BILI)\n4/30/14 - 5/2/24 5/2/19 - 5/2/24 4/30/19 - 5/2/24\n$100 4/20/2020 $300 7/26/2019 $180 2/10/2021\n$90 $94.14 $250 $234.90 $160 $156.37\n$80 PR", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 12, "type": "text"}}
{"content": "$94.14 $250 $234.90 $160 $156.37\n$80 PRI: 91 FRR: 100 $140 FRR: 100\n$200 $120\n$70\n$100\n$60 $150 10/31/2022\n10/26/2023 $80\n$50 10/12/2023 $8.92\n$100 $5.68 $60\n$40 $31.71 -94%\n-98% $40\n$30 -66% $50\n$20\n$0 $0\n5/2/19 5/2/20 5/2/21 5/2/22 5/2/23 5/2/24 4/30/19 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24\nEquity Risk Sciences, Inc. © 2025 (203) 254-0000\n12\nConfidential and Proprietary wwww.ERS.ai ww.ERS.ai", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 12, "type": "text"}}
{"content": "23andMe Holding Co (ME)\n11/23/20 - 5/2/24\n$20 2/4/2021\n$18 $17.65\n$16\nFRR: 100\n$14\n$12\n$10\n$8 4/17/2024\n$6 $0.36\n$4 -98%\n$2\n$0\n11/23/20 11/23/21 11/23/22 11/23/23 | AMC Entertainment (AMC)\n4/30/19 - 5/3/24\n$600\n6/2/2021\n$500 $551.91\nFRR: 100\n$400\n$300\n$200 4/15/2024\n$2.47…\n$100\n$0\n4/30/19 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 12, "type": "table"}}
{"content": "Bausch Health (BHC)\n4/30/20 - 5/2/24\n$40\n3/11/2021\n$35\n$34.38\n$30 FRR: 100\n$25\n$20 8/2/2022\n$4.58\n$15\n-87%\n$10\n$5\n$0\n4/30/20 4/30/21 4/30/22 4/30/23 4/30/24\nBilibili Inc (BILI)\n4/30/19 - 5/2/24\n$180 2/10/2021\n$160 $156.37\n$140 FRR: 100\n$120\n$100\n10/31/2022\n$80\n$8.92\n$60\n-94%\n$40\n$20\n$0\n4/30/19 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 12, "type": "table"}}
{"content": "2/4/2021 | \n$17.65 | \nFRR: 100 | \n | \n | \n | 4\n | \n | \n | \n | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 12, "type": "table"}}
{"content": "6/2 | /2021 |  |  | \n$5\nFRR | 51.91\n: 100 |  |  | \n |  |  |  | \n |  |  |  | \n |  |  |  | 4/15/202\n$2.47…\n |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 12, "type": "table"}}
{"content": " | 3 | /11/2021 |  | \n |  | $34.38 |  | \n | F | RR: 100 |  | \n |  | 8/2/2022 |  | \n |  | $4.58 |  | \n |  | -87% |  | \n |  |  |  | \n |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 12, "type": "table"}}
{"content": " | 4/20/2020 | \n | $94.14 | \n | PRI: 91 | \n |  | \n |  | \n |  | 10/12/20\n |  | $31.71\n-66%", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 12, "type": "table"}}
{"content": "7/2 | 6/2019 |  |  | \n$2\nFR | 34.90\nR: 100 |  |  | \n |  |  |  | \n |  |  | 1 | 0/26/202\n |  |  |  | $5.68\n-98%\n |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 12, "type": "table"}}
{"content": " |  | 2/10 | /2021 | \n |  | $15 | 6.37 | \n |  | FRR | : 100 | \n |  |  |  | \n |  |  |  | 10/31/\n |  |  |  | $8.9\n |  |  |  | -94\n |  |  |  | \n |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 12, "type": "table"}}
{"content": "ERS’ FRR R I C B T D\nS ELIABLY DENTIFIES OMPANIES EFORE HEY ECLINE\nBlock Inc (SQ) bluebird bio Inc (BLUE) C3.ai Inc (AI)\n4/30/19 - 5/2/24 4/29/16 - 5/2/24 12/9/30 - 5/3/24\n8/5/2021\n$300 $140 $200\n$281.81 3/12/2018 12/22/2020\n$120 $180\n$250 FRR: 96 $115.91 $160 $177.47\n$100 FRR: 100 FRR : 100\n$200 10/30/2023 $140\n$80\n$120\n$39.22 4/30/2024\n$150 $60 $100 12/29/2022\n-86% $0.89\n$40 $80 $10.90\n$100 -99%", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 13, "type": "text"}}
{"content": "2022\n-86% $0.89\n$40 $80 $10.90\n$100 -99%\n$20 $60 -94%\n$40\n$50\n$0\n$20\n$0 $0\n4/30/19 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24 12/9/20 12/9/21 12/9/22 12/9/23\nChewy Inc (CHWY) ContextLogic Inc (WISH) CRISPR Therapeutics (CRSP)\n6/14/19 - 5/2/24 12/16/20 - 5/2/24 4/30/19 - 5/2/24\n$140 $1,000 $240\n2/12/2021 1/14/2021\n$900 2/1/2021\n$120 $118.69 $210 $210.04\n$800 $935.70\n$100 FRR: 100 $700 FRR: 100 $180 FR", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 13, "type": "text"}}
{"content": "5.70\n$100 FRR: 100 $700 FRR: 100 $180 FRR: 100\n$80 4/30/2024 $600 $150 10/20/2023\n$14.99 $500 $38.62\n$60 $120\n-87% $400 10/27/2023 -82%\n$40 $300 $3.67 $90\n$200\n$20 -99.6% $60\n$100\n$0 $0 $30\n6/14/19 6/14/20 6/14/21 6/14/22 6/14/23 12/16/20 12/16/21 12/16/22 12/16/23 4/30/19 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24\nEquity Risk Sciences, Inc. © 2025 (203) 254-0000\n13\nConfidential and Proprietary wwww.", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 13, "type": "text"}}
{"content": "00\n13\nConfidential and Proprietary wwww.ERS.ai ww.ERS.ai", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 13, "type": "text"}}
{"content": "Block Inc (SQ)\n4/30/19 - 5/2/24\n8/5/2021\n$300\n$281.81\n$250 FRR: 96\n$200 10/30/2023\n$39.22\n$150\n-86%\n$100\n$50\n$0\n4/30/19 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24\nChewy Inc (CHWY)\n6/14/19 - 5/2/24\n$140\n2/12/2021\n$120 $118.69\n$100 FRR: 100\n$80 4/30/2024\n$14.99\n$60\n-87%\n$40\n$20\n$0\n6/14/19 6/14/20 6/14/21 6/14/22 6/14/23", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 13, "type": "table"}}
{"content": "bluebird bio Inc (BLUE)\n4/29/16 - 5/2/24\n$140\n3/12/2018\n$120\n$115.91\n$100 FRR: 100\n$80\n4/30/2024\n$60\n$0.89\n$40\n-99%\n$20\n$0\nContextLogic Inc (WISH)\n12/16/20 - 5/2/24\n$1,000\n$900 2/1/2021\n$800 $935.70\n$700 FRR: 100\n$600\n$500\n$400 10/27/2023\n$300\n$3.67\n$200\n-99.6%\n$100\n$0\n12/16/20 12/16/21 12/16/22 12/16/23", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 13, "type": "table"}}
{"content": "C3.ai Inc (AI)\n12/9/30 - 5/3/24\n$200\n12/22/2020\n$180\n$177.47\n$160\nFRR : 100\n$140\n$120\n$100 12/29/2022\n$80 $10.90\n$60 -94%\n$40\n$20\n$0\n12/9/20 12/9/21 12/9/22 12/9/23\nCRISPR Therapeutics (CRSP)\n4/30/19 - 5/2/24\n$240\n1/14/2021\n$210 $210.04\nFRR: 100\n$180\n$150 10/20/2023\n$38.62\n$120\n-82%\n$90\n$60\n$30\n4/30/19 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 13, "type": "table"}}
{"content": "$281.8 | 1 |  |  |  | \nFRR: 9 | 6 |  |  |  | \n |  |  | 10/\n$ | 30/2023\n39.22 | \n |  |  | - | 86% | \n |  |  |  |  | \n |  |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 13, "type": "table"}}
{"content": " | 3/12/2 | 018 |  |  |  | \n | $115. | 91 |  |  |  | \n | FRR: | 100 |  |  |  | \n |  |  |  | 4/30 | /2024 | \n |  |  |  | $0 | .89 | \n |  |  |  | -9 | 9% | \n |  |  |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 13, "type": "table"}}
{"content": "12/22 | /2020 |  | \n$17 | 7.47 |  | \nFRR | : 100 |  | \n |  |  | \n |  |  | \n | 12/29/2 |  | 022\n | $10.9 |  | 0\n | -94% |  | \n |  |  | \n |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 13, "type": "table"}}
{"content": "2/12/20 | 21 |  | \n$118.6\nFRR: 1 | 9\n00 |  | \n |  |  | \n |  |  | \n |  |  | \n |  |  | \n |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 13, "type": "table"}}
{"content": " |  | \n2/ | 1/2021 | \n$ | 935.70 | \nF | RR: 100 | \n |  | \n |  | \n |  | 10/27/2\n |  | $3.6\n |  | -99.6\n |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 13, "type": "table"}}
{"content": " |  | 1/14/2 | 021 |  | \n |  | $210\nFRR: | .04\n100 |  | \n |  |  |  |  | \n |  |  | 1 | 0/20/202\n$38.62 | \n |  |  |  | -82% | \n |  |  |  |  | \n |  |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 13, "type": "table"}}
{"content": "ERS’ FRR R I C B T D\nS ELIABLY DENTIFIES OMPANIES EFORE HEY ECLINE\nDoorDash Inc (DASH) DocuSign Inc (DOCU) Etsy Inc (ETSY)\n12/9/20 - 5/2/24 4/30/19 - 5/2/24 4/30/19 - 5/2/24\n9/3/2021\n$280 $330 $350\n11/12/2021 $310.05 11/24/2021\n$240 $245.97 $280 FRR: 100 $300 $296.91\nFRR: 100 FRR: 100\n$250\n$200 $230\n5/2/2024\n$200\n$160 10/14/2022 $180 $59.24\n10/27/2023 $150 -80%\n$43.06\n$120 $130 $38.53\n-82% $100\n-8", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 14, "type": "text"}}
{"content": "80%\n$43.06\n$120 $130 $38.53\n-82% $100\n-88%\n$80 $80\n$50\n$40 $30 $0\n12/9/20 12/9/21 12/9/22 12/9/23 4/30/19 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24 4/30/19 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24\nFannie Mae (FNMA) Fastly Inc (FSLY) Fiverr International (FVRR)\n12/31/94 - 12/31/09 5/17/19 - 5/2/24 6/13/19 - 5/2/24\n10/13/2020\n$120 $140 $350\n12/18/2000\n$128.83 2/12/2021\n$100 $87.81 $120 FRR: 100 $300 $3", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 14, "type": "text"}}
{"content": "2/2021\n$100 $87.81 $120 FRR: 100 $300 $323.10\nFRR: 100\n$100 $250 FRR: 100\n$80\n$80 $200\n10/14/2022\n$60\n$60 $7.44 $150 4/10/2024\n$40 -94% $19.22\n39773 $40 $100\n-94%\n$20 $0.30\n$20 $50\n-99.7%\n$0 $0 $0\n12/30/94 12/30/99 12/30/04 12/30/09 5/17/19 5/17/20 5/17/21 5/17/22 5/17/23 6/13/19 6/13/20 6/13/21 6/13/22 6/13/23\nEquity Risk Sciences, Inc. © 2025 (203) 254-0000\n14\nConfidential and Proprietary wwww.E", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 14, "type": "text"}}
{"content": "0\n14\nConfidential and Proprietary wwww.ERS.ai ww.ERS.ai", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 14, "type": "text"}}
{"content": "DoorDash Inc (DASH)\n12/9/20 - 5/2/24\n$280\n11/12/2021\n$245.97\n$240\nFRR: 100\n$200\n$160 10/14/2022\n$43.06\n$120\n-82%\n$80\n$40\n12/9/20 12/9/21 12/9/22 12/9/23\nFannie Mae (FNMA)\n12/31/94 - 12/31/09\n$120\n12/18/2000\n$100 $87.81\nFRR: 100\n$80\n$60\n$40\n39773\n$20 $0.30\n-99.7%\n$0\n12/30/94 12/30/99 12/30/04 12/30/09", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 14, "type": "table"}}
{"content": "DocuSign Inc (DOCU)\n4/30/19 - 5/2/24\n9/3/2021\n$330\n$310.05\n$280 FRR: 100\n$230\n$180\n10/27/2023\n$130 $38.53\n-88%\n$80\n$30\n4/30/19 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24\nFastly Inc (FSLY)\n5/17/19 - 5/2/24\n10/13/2020\n$140\n$128.83\n$120\nFRR: 100\n$100\n$80\n10/14/2022\n$60 $7.44\n-94%\n$40\n$20\n$0\n5/17/19 5/17/20 5/17/21 5/17/22 5/17/23", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 14, "type": "table"}}
{"content": "Etsy Inc (ETSY)\n4/30/19 - 5/2/24\n$350\n11/24/2021\n$300 $296.91\nFRR: 100\n$250\n5/2/2024\n$200\n$59.24\n$150 -80%\n$100\n$50\n$0\n4/30/19 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24\nFiverr International (FVRR)\n6/13/19 - 5/2/24\n$350\n2/12/2021\n$300\n$323.10\n$250 FRR: 100\n$200\n$150 4/10/2024\n$19.22\n$100\n-94%\n$50\n$0\n6/13/19 6/13/20 6/13/21 6/13/22 6/13/23", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 14, "type": "table"}}
{"content": "11/12\n$24\nFRR\n\n\n\n", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 14, "type": "table"}}
{"content": " |  |  |  | $310.0 | 5\n |  |  |  | FRR: 10 | 0\n |  |  |  |  | \n |  |  |  | 10 | /27/2023\n |  |  |  |  | $38.53\n-88%\n |  |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 14, "type": "table"}}
{"content": "11/ | 24/2021 |  |  | \n$2\nFR | 96.91\nR: 100 |  |  | \n |  |  |  | 5/2/20\n |  |  |  | $59.2\n |  |  |  | -80%\n |  |  |  | \n |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 14, "type": "table"}}
{"content": "12/18/2000 |  | \n$87.81\nFRR: 100 |  | \n |  | \n |  | \n | 39773 | \n | $0.30\n-99.7% | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 14, "type": "table"}}
{"content": " |  | $128. | 83\n |  | FRR: | 100\n |  |  | \n |  |  | 10/14/2\n |  |  | $7.4\n-94%\n |  |  | \n |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 14, "type": "table"}}
{"content": "2/12/20 | 21 |  | \n$323.1 | 0 |  | \nFRR: 1 | 00 |  | \n |  |  | \n |  |  | 4/10/2\n$19.\n |  |  | -94\n |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 14, "type": "table"}}
{"content": "ERS’ FRR R I C B T D\nS ELIABLY DENTIFIES OMPANIES EFORE HEY ECLINE\nGameStop Corp (GME) Lemonade Inc (LMND) NIO Inc (NIO)\n4/30/20 - 5/2/24 7/2/20 - 5/2/24 4/30/19 - 5/2/24\n$100 $200 $70 2/9/2021\n1/27/2021\n1/11/2021\n$90 $180 $62.84\n$86.88 $60\n$183.26\n$80 $160 FRR: 100\nFRR: 100\n$70 $140 FRR: 100 $50\n$60 4/22/2024 $120 $40 4/19/2024\n$50 $10.01 $100 4/27/2023\n$3.80\n$30\n$40 -88% $80 $10.57\n-94%\n$30 $60", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 15, "type": "text"}}
{"content": "80\n$30\n$40 -88% $80 $10.57\n-94%\n$30 $60 -94% $20\n$20 $40\n$10\n$10 $20\n$0 $0 $0\n4/30/20 4/30/21 4/30/22 4/30/23 4/30/24 7/2/20 7/2/21 7/2/22 7/2/23 4/30/19 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24\nNovavax Inc (NVAX) Okta Inc (OKTA) PayPal Holdings Inc (PYPL)\n4/30/19 - 5/2/24 4/30/19 - 5/2/24 4/30/19 - 5/2/24\n2/12/2021\n$350 $320 $350\n7/23/2021\n2/8/2021 $291.78\n$300 $319.93 $280 FRR: 100 $300 $308.53\nF", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 15, "type": "text"}}
{"content": "300 $319.93 $280 FRR: 100 $300 $308.53\nFRR: 100\n$250 FRR: 100 $240\n$250\n$200 $200 11/4/2022\n2/5/2024 $45.02 $200 10/27/2023\n$150 $160\n$3.76 -85% $50.39\n$150\n$100 -99% $120 -84%\n$100\n$50 $80\n$0 $40 $50\n4/30/19 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24 4/30/19 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24 4/30/19 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24\nEquity Risk Sciences, Inc. © 2025 (203) 254-0000\n15\nCon", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 15, "type": "text"}}
{"content": "ences, Inc. © 2025 (203) 254-0000\n15\nConfidential and Proprietary wwww.ERS.ai ww.ERS.ai", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 15, "type": "text"}}
{"content": "GameStop Corp (GME)\n4/30/20 - 5/2/24\n$100\n1/27/2021\n$90\n$86.88\n$80\nFRR: 100\n$70\n$60 4/22/2024\n$50 $10.01\n$40 -88%\n$30\n$20\n$10\n$0\n4/30/20 4/30/21 4/30/22 4/30/23 4/30/24\nNovavax Inc (NVAX)\n4/30/19 - 5/2/24\n$350\n2/8/2021\n$300\n$319.93\n$250 FRR: 100\n$200\n2/5/2024\n$150\n$3.76\n$100\n-99%\n$50\n$0\n4/30/19 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 15, "type": "table"}}
{"content": "Lemonade Inc (LMND)\n7/2/20 - 5/2/24\n$200\n1/11/2021\n$180\n$183.26\n$160\nFRR: 100\n$140\n$120\n$100 4/27/2023\n$80 $10.57\n$60 -94%\n$40\n$20\n$0\n7/2/20 7/2/21 7/2/22 7/2/23\nOkta Inc (OKTA)\n4/30/19 - 5/2/24\n2/12/2021\n$320\n$291.78\n$280 FRR: 100\n$240\n$200 11/4/2022\n$45.02\n$160\n-85%\n$120\n$80\n$40\n4/30/19 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 15, "type": "table"}}
{"content": "NIO Inc (NIO)\n4/30/19 - 5/2/24\n$70 2/9/2021\n$62.84\n$60\nFRR: 100\n$50\n$40 4/19/2024\n$3.80\n$30\n-94%\n$20\n$10\n$0\n4/30/19 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24\nPayPal Holdings Inc (PYPL)\n4/30/19 - 5/2/24\n$350\n7/23/2021\n$308.53\n$300\nFRR: 100\n$250\n$200 10/27/2023\n$50.39\n$150\n-84%\n$100\n$50\n4/30/19 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 15, "type": "table"}}
{"content": " | 1/27/2 | 021 |  | \n | $86. | 88 |  | \n | FRR: | 100 |  | \n |  |  |  | \n |  |  | 4/22/20 | \n |  |  | $10.01 | \n |  |  | -88% | \n |  |  |  | \n |  |  |  | \n |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 15, "type": "table"}}
{"content": " | 1/11/2021 |  | \n | $183.26 |  | \n | FRR: 100 |  | \n |  |  | \n |  |  | \n |  | 4/27/2 | \n |  | $10.5 | \n |  | -94% | \n |  |  | \n |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 15, "type": "table"}}
{"content": "2/9/20\n$62.8 | 21\n4 |  |  | \nFRR: 1 | 00 |  |  | \n |  |  |  | \n |  |  |  | 4/19/202\n$3.80\n |  |  |  | -94%\n |  |  |  | \n |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 15, "type": "table"}}
{"content": "2/8/20 | 21 |  |  |  | \n$319.\nFRR: | 93\n100 |  |  |  | \n |  |  |  |  | \n |  |  | 2/ | 5/2024 | \n |  |  |  | $3.76 | \n |  |  |  | -99% | \n |  |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 15, "type": "table"}}
{"content": "$291.7 | 8 |  |  |  | \nFRR: 1 | 00 |  |  |  | \n |  |  |  |  | \n |  |  | 11/4\n$4 |  | /2022\n5.02\n |  |  | -8 |  | 5%\n |  |  |  |  | \n |  |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 15, "type": "table"}}
{"content": " |  |  | 7/23/202\n$308.53 | 1 | \n |  |  | FRR: 10 | 0 | \n |  |  |  |  | \n |  |  | 1 | 0/27/202\n$50.39 | \n |  |  |  | -84% | \n |  |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 15, "type": "table"}}
{"content": "ERS’ FRR R I C B T D\nS ELIABLY DENTIFIES OMPANIES EFORE HEY ECLINE\nPeloton Interactive Inc (PTON) Roku Inc (ROKU) Sea Ltd (SE)\n9/26/19 - 5/2/24 4/30/19 - 5/2/24 4/30/19 - 5/2/24\n$180 1/13/2021 $600 $400\n7/26/2021 10/19/2021\n$160 $167.42 $350\n$500 $479.50 $366.99\n$140 FRR: 100\nFRR: 100 $300 FRR: 100\n$120 $400\n$250\n$100 12/28/2022 1/17/2024\n$300 $200\n$80 $38.80 $34.82\n4/19/2024\n$60 $200 -92% $150 -9", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 16, "type": "text"}}
{"content": "0 $34.82\n4/19/2024\n$60 $200 -92% $150 -91%\n$3.03\n$100\n$40\n-98%\n$100\n$20 $50\n$0 $0 $0\n9/26/19 9/26/20 9/26/21 9/26/22 9/26/23 4/30/19 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24 4/30/19 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24\nSkillz Inc (SKLZ) Snowflake Inc (SNOW) Teladoc Health Inc (TDOC)\n4/30/20 - 5/2/24 4/30/21 - 5/2/24 4/30/19 - 5/2/24\n$1,000 $450 $350\n2/5/2021 11/16/2021 2/8/2021\n$900 $400\n$874.40", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 16, "type": "text"}}
{"content": "21 11/16/2021 2/8/2021\n$900 $400\n$874.40 $401.89 $300 $294.54\n$800 $350\nFRR: 100 FRR: 100 FRR: 100\n$700 $250\n$300\n$600\n$250 $200\n$500\n$200 $150 4/30/2024\n$400 10/5/2023\n$150 $12.75\n$300 $4.12 6/13/2022 $100\n$100 -96%\n$200 -99.5%\n$113.30 $50\n$100 $50\n-72%\n$0 $0 $0\n4/30/20 4/30/21 4/30/22 4/30/23 4/30/24 4/30/21 4/30/22 4/30/23 4/30/24 4/30/19 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24\nEquity Risk Scie", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 16, "type": "text"}}
{"content": "4/30/22 4/30/23 4/30/24\nEquity Risk Sciences, Inc. © 2025 (203) 254-0000\n16\nConfidential and Proprietary wwww.ERS.ai ww.ERS.ai", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 16, "type": "text"}}
{"content": "Peloton Interactive Inc (PTON)\n9/26/19 - 5/2/24\n$180 1/13/2021\n$160 $167.42\n$140 FRR: 100\n$120\n$100\n$80\n4/19/2024\n$60\n$3.03\n$40\n-98%\n$20\n$0\n9/26/19 9/26/20 9/26/21 9/26/22 9/26/23\nSkillz Inc (SKLZ)\n4/30/20 - 5/2/24\n$1,000\n2/5/2021\n$900\n$874.40\n$800\nFRR: 100\n$700\n$600\n$500\n$400 10/5/2023\n$300 $4.12\n$200 -99.5%\n$100\n$0\n4/30/20 4/30/21 4/30/22 4/30/23 4/30/24", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 16, "type": "table"}}
{"content": "Roku Inc (ROKU)\n4/30/19 - 5/2/24\n$600\n7/26/2021\n$500 $479.50\nFRR: 100\n$400\n12/28/2022\n$300\n$38.80\n-92%\n$200\n$100\n$0\n4/30/19 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24\nSnowflake Inc (SNOW)\n4/30/21 - 5/2/24\n$450\n11/16/2021\n$400\n$401.89\n$350\nFRR: 100\n$300\n$250\n$200\n$150\n6/13/2022\n$100\n$113.30\n$50\n-72%\n$0\n4/30/21 4/30/22 4/30/23 4/30/24", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 16, "type": "table"}}
{"content": "Sea Ltd (SE)\n4/30/19 - 5/2/24\n$400\n10/19/2021\n$350\n$366.99\n$300 FRR: 100\n$250\n1/17/2024\n$200\n$34.82\n$150 -91%\n$100\n$50\n$0\n4/30/19 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24\nTeladoc Health Inc (TDOC)\n4/30/19 - 5/2/24\n$350\n2/8/2021\n$300 $294.54\nFRR: 100\n$250\n$200\n$150 4/30/2024\n$12.75\n$100\n-96%\n$50\n$0\n4/30/19 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 16, "type": "table"}}
{"content": " | 1 | /13/2021 |  | \n |  | $167.42 |  | \n |  | FRR: 100 |  | \n |  |  |  | \n |  |  |  | \n |  |  | 4/1 | \n |  |  | $ | \n |  |  | - | \n |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 16, "type": "table"}}
{"content": "7/26/2 | 021 |  |  | \n$479.\nFRR: 1 | 50\n00 |  |  | \n |  |  | 12/28/2 | 022\n |  |  | $38.8\n-92 | 0\n%\n |  |  |  | \n |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 16, "type": "table"}}
{"content": "10/19/ | 2021 |  |  |  | \n$366 | .99 |  |  |  | \nFRR: | 100 |  |  |  | \n |  |  | 1/ | 17/2024 | \n |  |  |  | $34.82 | \n |  |  |  | -91% | \n |  |  |  |  | \n |  |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 16, "type": "table"}}
{"content": " | 2/5/20 | 21 |  | \n | $874.4 | 0 |  | \n | FRR: 1 | 00 |  | \n |  |  |  | \n |  |  |  | \n |  |  |  | \n |  | 1 | 0/5/2023 | \n |  |  | $4.12 | \n |  |  | -99.5% | \n |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 16, "type": "table"}}
{"content": " | 11/16/2021 | \n | $401.89 | \n | FRR: 100 | \n |  | \n |  | \n |  | \n6/13/2022 |  | \n$113.30 |  | \n-72% |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 16, "type": "table"}}
{"content": " |  | 2/8/2 | 021 | \n |  | $294.\nFRR: | 54\n100 | \n |  |  |  | \n |  |  |  | \n |  |  | 4 | /30/202\n$12.75\n |  |  |  | -96%\n |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 16, "type": "table"}}
{"content": "ERS’ FRR R I C B T D\nS ELIABLY DENTIFIES OMPANIES EFORE HEY ECLINE\nTwilio Inc (TWLO) UiPath Inc (PATH) Unity Software Inc (U)\n4/30/19 - 5/2/24 4/21/21 - 5/2/24 9/18/20 - 5/2/24\n$500 2/18/2021 $90 5/24/2021 $250 11/18/2021\n$450 $443.49 $80 $85.12 $201.12\n$400 FRR: 100 $70 FRR: 100 $200 FRR: 100\n$350\n$60\n$300 $150\n11/4/2022 11/9/2022\n$250 $50 11/9/2022\n$42.74 $21.50\n$200 $40 $10.55 $100\n-90% -89%\n$1", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 17, "type": "text"}}
{"content": "$21.50\n$200 $40 $10.55 $100\n-90% -89%\n$150 -88%\n$30\n$100 $50\n$20\n$50\n$0 $10 $0\n4/30/19 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24 4/21/21 4/21/22 4/21/23 4/21/24 9/18/20 9/18/21 9/18/22 9/18/23\nUpstart Holdings Inc (UPST) Value Line Inc (VALU) Zoom Video (ZM)\n12/16/20 - 5/2/24 4/30/21 - 5/2/24 4/30/19 - 5/2/24\n$450 $120 $600\n10/15/2021 8/26/2022 10/19/2020\n$400 $390.00 $100 $100.89 $500 $568.34\n$350", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 17, "type": "text"}}
{"content": "$390.00 $100 $100.89 $500 $568.34\n$350 FRR: 100 FRR: 100 FRR: 100\n$300 $80 $400\n$250\n5/2/2023 $60 $300 4/17/2024\n$200\n$12.10 $59.08\n$150 $40 $200\n-97% -90%\n$100\n10/12/2023\n$20 $100\n$50\n$32.50\n$0 $0 -68% $0\n12/16/20 12/16/21 12/16/22 12/16/23 4/30/21 4/30/22 4/30/23 4/30/24 4/30/19 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24\nEquity Risk Sciences, Inc. © 2025 (203) 254-0000\n17\nConfidential and Propriet", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 17, "type": "text"}}
{"content": "3) 254-0000\n17\nConfidential and Proprietary wwww.ERS.ai ww.ERS.ai", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 17, "type": "text"}}
{"content": "Twilio Inc (TWLO)\n4/30/19 - 5/2/24\n$500 2/18/2021\n$450 $443.49\n$400 FRR: 100\n$350\n$300\n11/4/2022\n$250\n$42.74\n$200\n-90%\n$150\n$100\n$50\n$0\n4/30/19 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24\nUpstart Holdings Inc (UPST)\n12/16/20 - 5/2/24\n$450\n10/15/2021\n$400\n$390.00\n$350\nFRR: 100\n$300\n$250\n5/2/2023\n$200\n$12.10\n$150\n-97%\n$100\n$50\n$0\n12/16/20 12/16/21 12/16/22 12/16/23", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 17, "type": "table"}}
{"content": "UiPath Inc (PATH)\n4/21/21 - 5/2/24\n$90 5/24/2021\n$80 $85.12\nFRR: 100\n$70\n$60\n$50 11/9/2022\n$40 $10.55\n-88%\n$30\n$20\n$10\n4/21/21 4/21/22 4/21/23 4/21/24\nValue Line Inc (VALU)\n4/30/21 - 5/2/24\n$120\n8/26/2022\n$100.89\n$100\nFRR: 100\n$80\n$60\n$40\n10/12/2023\n$20\n$32.50\n$0 -68%\n4/30/21 4/30/22 4/30/23 4/30/24", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 17, "type": "table"}}
{"content": "Unity Software Inc (U)\n9/18/20 - 5/2/24\n$250\n11/18/2021\n$201.12\n$200\nFRR: 100\n$150\n11/9/2022\n$21.50\n$100\n-89%\n$50\n$0\n9/18/20 9/18/21 9/18/22 9/18/23\nZoom Video (ZM)\n4/30/19 - 5/2/24\n$600\n10/19/2020\n$568.34\n$500\nFRR: 100\n$400\n$300 4/17/2024\n$59.08\n$200\n-90%\n$100\n$0\n4/30/19 4/30/20 4/30/21 4/30/22 4/30/23 4/30/24", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 17, "type": "table"}}
{"content": "2/18/20 | 21 |  |  |  | \n$443.4 | 9 |  |  |  | \nFRR: 1 | 00 |  |  |  | \n |  |  |  |  | \n |  |  | 11/4/ |  | 2022\n |  |  | $42 |  | .74\n |  |  | -9 |  | 0%\n |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 17, "type": "table"}}
{"content": "5/24/ | 2021 |  | \n$85\nFRR: | .12\n100 |  | \n |  |  | \n |  |  | \n | 11/9/2022\n$10.55 |  | \n | -88% |  | \n |  |  | \n |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 17, "type": "table"}}
{"content": "11/18/202\n$201.12 | 1 | \nFRR: 100 |  | \n | 1 | 1/9/2022\n$21.50\n |  | -89%\n |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 17, "type": "table"}}
{"content": " | 10/15/202 | 1 | \n | $390.00 |  | \n | FRR: 100 |  | \n |  |  | \n | 5/ | 2/2023 | \n | $ | 12.10 | \n |  | -97% | \n |  |  | \n |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 17, "type": "table"}}
{"content": "8/26/2022 |  | \n$100.89\nFRR: 100 |  | \n |  | \n |  | \n |  | 10/12/2023\n |  | $32.50", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 17, "type": "table"}}
{"content": " |  | 10/19/2\n$568. | 020\n34 | \n |  | FRR: 1 | 00 | \n |  |  |  | \n |  |  | 4/ | 17/2024\n$59.08\n |  |  |  | -90%\n |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 17, "type": "table"}}
{"content": "INVESTORS LACKING RELIABLE DATA ANALYSIS BUY THE LARGEST AND MOST POPULAR STOCKS.\nERS’S RATINGS INDICATE OF A STOCK’S SAFETY AND THE PROBABILITY OF ITS FUTURE PRICE CHANGES\nMicrosoft - 12/31/99 to 10/16/14 Eli Lilly - 8/8/00 to 10/25/11 NVIDIA - 1/3/02 to 5/20/13\n500% 150% 133% 400%\n15 Years 11 Years 13 Years\n400% 425% 298%\nRevenue Growth: 425% Revenue Growth: 133% Revenue Growth: 298%\n100% 300%\n3", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 18, "type": "text"}}
{"content": "h: 133% Revenue Growth: 298%\n100% 300%\n300% Price Gain: 1% Price Loss: -50% Price Loss: -6%\n200% 206% 50% 200%\n100%\n0% 100%\n0% 1% -50% -6%\n-50% 0%\n-100%\n12/31/99 12/31/04 12/31/09 12/31/14\n-100% -100%\n8/8/00 8/8/03 8/8/06 8/8/09 1/3/02 1/3/05 1/3/08 1/3/11\nTotal Return Revenue per share\nNet Income per share Total Return Revenue Total Return Revenue\nIntel - 8/31/00 to 10/11/22 Cisco - 3/27/00 to 4/", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 18, "type": "text"}}
{"content": "/31/00 to 10/11/22 Cisco - 3/27/00 to 4/30/24 Amazon - 12/10/99 to 7/2/10\n2256%\n150% 22 Years 400% 2400%\n24 Years 10 ½ Years\nRevenue Growth: 118%\n281%\n100% Price Loss: -44% 118% 300% Revenue Growth: 281% 1900% Revenue Growth: 2,256%\nPrice Loss: -14% Price Gain: 2%\n50% 200% 1400%\n0% 100% 900%\n-50% 0% 400%\n-44%\n-14%\n2%\n-100% -100% -100%\n8/31/00 8/31/05 8/31/10 8/31/15 8/31/20 3/27/00 3/27/05 3/27/10", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 18, "type": "text"}}
{"content": "8/31/15 8/31/20 3/27/00 3/27/05 3/27/10 3/27/15 3/27/20 12/10/99 12/10/04 12/10/09\nTotal Return Revenue Total Return Revenue Total Return Revenue\nEquity Risk Sciences, Inc. © 2025 (203) 254-0000\n18\nConfidential and Proprietary wwww.ERS.ai ww.ERS.ai", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 18, "type": "text"}}
{"content": "Microsoft - 12/31/99 to 10/16/14\n500%\n15 Years\n425%\n400%\nRevenue Growth: 425%\n300% Price Gain: 1%\n200% 206%\n100%\n0% 1%\n-100%\n12/31/99 12/31/04 12/31/09 12/31/14\nTotal Return Revenue per share\nNet Income per share\nIntel - 8/31/00 to 10/11/22\n150% 22 Years\nRevenue Growth: 118%\n100% Price Loss: -44% 118%\n50%\n0%\n-50%\n-44%\n-100%\n8/31/00 8/31/05 8/31/10 8/31/15 8/31/20\nTotal Return Revenue", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 18, "type": "table"}}
{"content": "Eli Lilly - 8/8/00 to 10/25/11\n150% 133%\n11 Years\nRevenue Growth: 133%\n100%\nPrice Loss: -50%\n50%\n0%\n-50%\n-50%\n-100%\n8/8/00 8/8/03 8/8/06 8/8/09\nTotal Return Revenue\nCisco - 3/27/00 to 4/30/24\n400%\n24 Years\n281%\n300% Revenue Growth: 281%\nPrice Loss: -14%\n200%\n100%\n0%\n-14%\n-100%\n3/27/00 3/27/05 3/27/10 3/27/15 3/27/20\nTotal Return Revenue", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 18, "type": "table"}}
{"content": "NVIDIA - 1/3/02 to 5/20/13\n400%\n13 Years\n298%\nRevenue Growth: 298%\n300%\nPrice Loss: -6%\n200%\n100%\n-6%\n0%\n-100%\n1/3/02 1/3/05 1/3/08 1/3/11\nTotal Return Revenue\nAmazon - 12/10/99 to 7/2/10\n2256%\n2400%\n10 ½ Years\n1900% Revenue Growth: 2,256%\nPrice Gain: 2%\n1400%\n900%\n400%\n2%\n-100%\n12/10/99 12/10/04 12/10/09\nTotal Return Revenue", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 18, "type": "table"}}
{"content": " |  | 15 | Y | ear | s |  |  |  |  | \nRev | en\nPr | ue\nice | Gr\nG | owt\nain: | h:\n1 | 42\n% | 5% |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 18, "type": "table"}}
{"content": "Re | ven | 11\nue | Yea\nGrow | rs\nth: | 133 | % |  |  |  | 1\n | Pri | ce L | oss: | -50 | % |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | -\n |  |  |  |  |  |  |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 18, "type": "table"}}
{"content": "R | even | 13\nue | Years\nGrowt | h: 298 | % |  | \n | Pr | ice | Loss: | -6% |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 18, "type": "table"}}
{"content": " |  |  |  |  |  |  |  |  |  |  |  |  |  | \nRev | en | u | 22\ne | Y\nGr | ea\no | r\nwt | s\nh: | 1 | 18 | % |  |  |  | \n | Pri | ce |  | Los | s | : - | 44 | % |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 18, "type": "table"}}
{"content": "Re | ven | 24\nue | Y\nGr | ea\no | rs\nwt | h: | 2 | 81 | % |  |  |  |  |  |  |  |  | \n | Pri | ce L | os | s | : - | 1 | 4% |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 18, "type": "table"}}
{"content": "R | even | 10\nue | ½ Ye\nGrowt | ars\nh: 2,2 | 56% |  |  | \n |  | Price | Gain | : 2% |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 18, "type": "table"}}
{"content": "ERS’ F R R (FRR ):\nS IDUCIARY ISK ATING\nA A R L I F\nN CCURATE AND ELIABLE OSS NDICATOR FOR IDUCIARIES\nERS’s Fiduciary Risk Rating is a revolutionary stock rating technology that accurately measures and rates the\nstatistical probability, magnitude, and approximate timing of stock price declines.\nThe Fiduciary Risk Rating helps advisors reduce, avoid and prevent losses.\nAverage 1-Year Return\n12/31/2", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 19, "type": "text"}}
{"content": "nt losses.\nAverage 1-Year Return\n12/31/21 to 12/31/22\n0%\n0.0%\n-5%\n-10%\n-11.8%\n-15%\n-20%\n-18.1%\n-25%\n-25.4%\n-30%\n0 to 25 25 to 75 75 to 100 S&P 500\n(77 co's) (905 co's) (1518 co's)\nFRR v1.3\nEquity Risk Sciences, Inc. © 2025 (203) 254-0000\n19\nConfidential and Proprietary wwww.ERS.ai ww.ERS.ai", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 19, "type": "text"}}
{"content": "0.0% |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  | \n | -11.8% |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  | -18.1% |  | \n |  |  |  | -25.4% |  |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 19, "type": "table"}}
{"content": "5 Y R : ERS’ F R R (FRR )\nEAR ESULTS S IDUCIARY ISK ATING\nI T P - B -P C\nDENTIFIED HE OOREST AND EST ERFORMING OMPANIES\n12/31/2017 TO 12/31/2022\n5-year study of price changes on\n5-Year Total Return\n5,023 stocks using ERS’s FRR\nbetween 12/31/17 and 12/31/22: 0 to 10 12/31/2017 to 12/31/2022\n40%\nOn 12/31/17, 5,023 companies traded in the US with 37%\na market cap over $100 million.\n35%\nThis study dem", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 20, "type": "text"}}
{"content": "ap over $100 million.\n35%\nThis study demonstrates that companies with the\nworst FRR ratings rose much less than both the\nbest-rated companies and the average of all the 30%\ncompanies.\n24%\nAll Co’s\n25%\nAvg 5-Year\nFRR # Co’s\n20%\nReturn\n20%\n0 to 10 65 37%\n10 to 99 3,672 24% 15%\n100 only 1,286 6%\n10%\n6%\nAll Co’s 5,023 20%\n5%\nConclusion: Companies with ERS’s worst\nFRR ratings underperformed both the\n0%", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 20, "type": "text"}}
{"content": "t\nFRR ratings underperformed both the\n0%\naverage stock and stocks with ERS’s best\n0 to 10 10 to 99 100 only All Co's\nratings.\nEquity Risk Sciences, Inc. © 2025 (203) 254-0000\n20\nConfidential and Proprietary wwww.ERS.ai ww.ERS.ai", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 20, "type": "text"}}
{"content": "37% |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  | 24% |  |  |  |  |  | All Co’s |  | \n |  |  |  |  |  |  |  |  | 20% |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  | 6% |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | ", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 20, "type": "table"}}
{"content": "FRR | # Co’s | Avg 5-Year\nReturn\n0 to 10 | 65 | 37%\n10 to 99 | 3,672 | 24%\n100 only | 1,286 | 6%\nAll Co’s | 5,023 | 20%", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 20, "type": "table"}}
{"content": "D & F -L L\nISCLAIMER ORWARD OOKING ANGUAGE\nThis presentation shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any jurisdiction in\nwhich such offer, solicitation or sale would be unlawful. Nothing contained in this presentation should be construed as legal, tax, financial, investment, or\nother advice.\nIn addition to hist", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 21, "type": "text"}}
{"content": "nt, or\nother advice.\nIn addition to historical information, this presentation contains statements relating to the future business performance, future catalysts and future events\nor developments, strategy, prospects, plans, objectives of management and future operations, and expected market growth of Equity Risk Sciences, Inc.\n(the “Company,”) that may constitute “forward-looking statements” within", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 21, "type": "text"}}
{"content": "tute “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation\nReform Act of 1995. The words \"believe,\" “can make,” “intend,” “could,” “currently,” “will,” \"expect\" and similar expressions, as they relate to us, are intended\nto identify forward-looking statements. We have based these forward-looking statements largely on our current expect", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 21, "type": "text"}}
{"content": "statements largely on our current expectations and projections about future\nevents and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Important factors\nthat could cause actual results to differ from those in the forward-looking statements include but are not limited to the successful commercialization of our\nrisk r", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 21, "type": "text"}}
{"content": "ccessful commercialization of our\nrisk rating system and solutions, development of our sales and marketing capabilities, our ability to retain key management personnel including our\nFounder Ray Mullaney as well as Thomas Harpin, acceptance of our solutions by potential customers, the ability of our risk rating systems and solutions to\nprovide valuable information related to a company’s stock price", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 21, "type": "text"}}
{"content": "ation related to a company’s stock price, and intellectual property litigation, and our ability to raise capital necessary for ongoing\noperations. The statements made herein speak only as of the date of this presentation. The Company’s actual results, performance or achievements could\ndiffer materially from the results expressed in, or implied by, these forward-looking statements. The Company unde", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 21, "type": "text"}}
{"content": "ard-looking statements. The Company undertakes no obligation to update or revise\nits forward-looking statements to reflect events or circumstances after the date of this presentation, except as required by law.\nMarket data and industry information used herein are based on our management's knowledge of the industry and the good faith estimates of management.\nWe also relied, to the extent available,", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 21, "type": "text"}}
{"content": "We also relied, to the extent available, upon managements review of independent industry surveys, forecasts and publications and other publicly available\ninformation prepared by a number of third-party sources. All of the market data and industry information used herein involves a number of assumptions\nand limitations which we believe to be reasonable, and you are cautioned not to give undue weigh", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 21, "type": "text"}}
{"content": "ou are cautioned not to give undue weight to such estimates. Although we believe that these\nsources are reliable, we cannot guarantee the accuracy or completeness of this information, and we have not independently verified this information.\nProjections, assumptions and estimates of our future performance and the future performance of the industry in which we operate are subject to a high\ndegree of", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 21, "type": "text"}}
{"content": "operate are subject to a high\ndegree of uncertainty and risk due to a variety of factors, including those described, above. These and other factors could cause results to differ materially\nfrom those expressed in our estimates and beliefs and in the estimates prepared by independent parties. In all cases, you should conduct your own\ninvestigation and analysis of the Company and the information co", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 21, "type": "text"}}
{"content": "is of the Company and the information contained in this presentation. All estimates and forecasts are subject to change and past\nresults are not necessarily an indication of future performance.\nEquity Risk Sciences, Inc. © 2025 (203) 254-0000\n21\nConfidential and Proprietary wwww.ERS.ai ww.ERS.ai", "metadata": {"source": "ERS-Preventing-Losses-Feb-25-2025-3pm.pdf", "page": 21, "type": "text"}}
